| Disease Term | Human Homologs | Mouse Homologs | Mouse Models | Homology Source | |||
  | adrenoleukodystrophy | ABCD1* | Abcd1* | 9 models | Alliance of Genome Resources | ||
| adult-onset autosomal dominant demyelinating leukodystrophy | LMNB1* | Lmnb1* | 1 model | Alliance of Genome Resources | |||
| agenesis of the corpus callosum with peripheral neuropathy | SLC12A6* | Slc12a6* | 3 models | Alliance of Genome Resources | |||
| Alexander disease | GFAP* | Gfap* | 4 models | Alliance of Genome Resources | |||
| alternating hemiplegia of childhood | ATP1A3* | Atp1a3* | 4 models | Alliance of Genome Resources | |||
| Alzheimer's disease | PSEN1* | Psen1* | 19 models | Alliance of Genome Resources | |||
| Alzheimer's disease | PLAU* | Plau* | 1 model | Alliance of Genome Resources | |||
| Alzheimer's disease | MME* | Mme* | 1 model | Alliance of Genome Resources | |||
| Alzheimer's disease | LRP1* | Lrp1* | 2 models | Alliance of Genome Resources | |||
| Alzheimer's disease | APP* | App* | 24 models | Alliance of Genome Resources | |||
| Alzheimer's disease 3 | PSEN1* | Psen1* | 6 models | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis type 1 | SOD1* | Sod1* | 2 models | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis type 10 | TARDBP* | Tardbp* | 7 models | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis type 21 | MATR3* | Matr3* | 1 model | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis type 4 | SETX* | Setx* | 1 model | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis type 6 | FUS* | Fus* | 1 model | Alliance of Genome Resources | |||
| arteriovenous malformations of the brain | ENG* | Eng* | 1 model | Alliance of Genome Resources | |||
| arteriovenous malformations of the brain | KRAS* | Kras* | 2 models | Alliance of Genome Resources | |||
| ataxia telangiectasia | ATM* | Atm* | 9 models | Alliance of Genome Resources | |||
| Athabaskan brainstem dysgenesis syndrome | HOXA1* | Hoxa1* | 1 model | Alliance of Genome Resources | |||
| atypical teratoid rhabdoid tumor | SMARCB1* | Smarcb1* | 3 models | Alliance of Genome Resources | |||
| autosomal dominant distal hereditary motor neuronopathy 2 | HSPB8* | Hspb8* | 1 model | Alliance of Genome Resources | |||
| autosomal dominant nocturnal frontal lobe epilepsy 3 | CHRNB2* | Chrnb2* | 2 models | Alliance of Genome Resources | |||
| autosomal recessive distal hereditary motor neuronopathy 1 | IGHMBP2* | Ighmbp2* | 2 models | Alliance of Genome Resources | |||
| autosomal recessive spinocerebellar ataxia 12 | WWOX* | Wwox* | 1 model | Alliance of Genome Resources | |||
| autosomal recessive spinocerebellar ataxia 13 | GRM1* | Grm1* | 1 model | Alliance of Genome Resources | |||
| autosomal recessive spinocerebellar ataxia 16 | STUB1* | Stub1* | 1 model | Alliance of Genome Resources | |||
| autosomal recessive spinocerebellar ataxia 18 | GRID2* | Grid2* | 2 models | Alliance of Genome Resources | |||
| basal ganglia calcification | SLC20A2* | Slc20a2* | 1 model | Alliance of Genome Resources | |||
| basal ganglia calcification | PDGFRB* | Pdgfrb* | 1 model | Alliance of Genome Resources | |||
| benign neonatal seizures | KCNQ2* | Kcnq2* | 5 models | Alliance of Genome Resources | |||
| benign neonatal seizures | KCNQ3* | Kcnq3* | 5 models | Alliance of Genome Resources | |||
| biotin-responsive basal ganglia disease | SLC19A3* | Slc19a3* | 2 models | Alliance of Genome Resources | |||
| brain small vessel disease 1 | COL4A1* | Col4a1* | 1 model | Alliance of Genome Resources | |||
| CADASIL 1 | NOTCH3* | Notch3* | 6 models | Alliance of Genome Resources | |||
| Canavan disease | ASPA* | Aspa* | 5 models | Alliance of Genome Resources | |||
| Cayman type cerebellar ataxia | ATCAY* | Atcay* | 3 models | Alliance of Genome Resources | |||
| cerebellar ataxia type 42 | CACNA1G* | Cacna1g* | 2 models | Alliance of Genome Resources | |||
| cerebral cavernous malformation | KRIT1* | Krit1* | 1 model | Alliance of Genome Resources | |||
| cerebral cavernous malformation 2 | CCM2* | Ccm2* | 4 models | Alliance of Genome Resources | |||
| cerebral cavernous malformation 3 | PDCD10* | Pdcd10* | 2 models | Alliance of Genome Resources | |||
| Charlevoix-Saguenay spastic ataxia | SACS* | Sacs* | 2 models | Alliance of Genome Resources | |||
| choreaacanthocytosis | VPS13A* | Vps13a* | 1 model | Alliance of Genome Resources | |||
| complex cortical dysplasia with other brain malformations 4 | TUBG1* | Tubg1* | 1 model | Alliance of Genome Resources | |||
| complex cortical dysplasia with other brain malformations 7 | TUBB2B* | Tubb2b* | 1 model | Alliance of Genome Resources | |||
| cortical dysplasia-focal epilepsy syndrome | CNTNAP2* | Cntnap2* | 1 model | Alliance of Genome Resources | |||
| Creutzfeldt-Jakob disease | PRNP* | Prnp* | 8 models | Alliance of Genome Resources | |||
| Dandy-Walker syndrome | ZIC1* | Zic1* | 1 model | Alliance of Genome Resources | |||
| developmental and epileptic encephalopathy 14 | KCNT1* | Kcnt1* | 2 models | Alliance of Genome Resources | |||
| developmental and epileptic encephalopathy 16 | TBC1D24* | Tbc1d24* | 1 model | Alliance of Genome Resources | |||
| developmental and epileptic encephalopathy 17 | GNAO1* | Gnao1* | 3 models | Alliance of Genome Resources | |||
| developmental and epileptic encephalopathy 2 | CDKL5* | Cdkl5* | 2 models | Alliance of Genome Resources | |||
| developmental and epileptic encephalopathy 39 | SLC25A12* | Slc25a12* | 1 model | Alliance of Genome Resources | |||
| developmental and epileptic encephalopathy 54 | HNRNPU* | Hnrnpu* | 1 model | Alliance of Genome Resources | |||
| developmental and epileptic encephalopathy 7 | KCNQ2* | Kcnq2* | 1 model | Alliance of Genome Resources | |||
| Dravet syndrome | SCN1A* | Scn1a* | 8 models | Alliance of Genome Resources | |||
| episodic ataxia type 1 | KCNA1* | Kcna1* | 1 model | Alliance of Genome Resources | |||
| episodic ataxia type 2 | CACNA1A* | Cacna1a* | 3 models | Alliance of Genome Resources | |||
| episodic kinesigenic dyskinesia 1 | PRRT2* | Prrt2* | 2 models | Alliance of Genome Resources | |||
| familial encephalopathy with neuroserpin inclusion bodies | SERPINI1* | Serpini1* | 1 model | Alliance of Genome Resources | |||
| familial hemiplegic migraine 2 | ATP1A2* | Atp1a2* | 2 models | Alliance of Genome Resources | |||
| familial temporal lobe epilepsy 1 | LGI1* | Lgi1* | 4 models | Alliance of Genome Resources | |||
| fatal familial insomnia | PRNP* | Prnp* | 1 model | Alliance of Genome Resources | |||
| fragile X-associated tremor/ataxia syndrome | FMR1* | Fmr1* | 1 model | Alliance of Genome Resources | |||
| Friedreich ataxia | FXN* | Fxn* | 8 models | Alliance of Genome Resources | |||
| frontotemporal dementia | CHMP2B* | Chmp2b* | 1 model | Alliance of Genome Resources | |||
| generalized epilepsy with febrile seizures plus | SCN1A* | Scn1a* | 5 models | Alliance of Genome Resources | |||
| Gerstmann-Straussler-Scheinker syndrome | PRNP* | Prnp* | 7 models | Alliance of Genome Resources | |||
| Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | GRN* | Grn* | 3 models | Alliance of Genome Resources | |||
| hereditary spastic paraplegia 11 | SPG11* | Spg11* | 1 model | Alliance of Genome Resources | |||
| hereditary spastic paraplegia 13 | HSPD1* | Hspd1* | 1 model | Alliance of Genome Resources | |||
| hereditary spastic paraplegia 15 | ZFYVE26* | Zfyve26* | 1 model | Alliance of Genome Resources | |||
| hereditary spastic paraplegia 2 | PLP1* | Plp1* | 2 models | Alliance of Genome Resources | |||
| hereditary spastic paraplegia 30 | KIF1A* | Kif1a* | 2 models | Alliance of Genome Resources | |||
| hereditary spastic paraplegia 31 | REEP1* | Reep1* | 1 model | Alliance of Genome Resources | |||
| hereditary spastic paraplegia 35 | FA2H* | Fa2h* | 1 model | Alliance of Genome Resources | |||
| hereditary spastic paraplegia 4 | SPAST* | Spast* | 3 models | Alliance of Genome Resources | |||
| hereditary spastic paraplegia 48 | AP5Z1* | Ap5z1* | 1 model | Alliance of Genome Resources | |||
| hereditary spastic paraplegia 54 | DDHD2* | Ddhd2* | 1 model | Alliance of Genome Resources | |||
| hereditary spastic paraplegia 7 | SPG7* | Spg7* | 1 model | Alliance of Genome Resources | |||
| hereditary spastic paraplegia 80 | UBAP1* | Ubap1* | 1 model | Alliance of Genome Resources | |||
| Huntington's disease | HTT* | Htt* | 21 models | Alliance of Genome Resources | |||
| hydrocephalus | TRIM71* | Trim71* | 1 model | Alliance of Genome Resources | |||
| hypomyelinating leukodystrophy 2 | GJC2* | Gjc2* | 3 models | Alliance of Genome Resources | |||
| hypomyelinating leukodystrophy 6 | TUBB4A* | Tubb4a* | 3 models | Alliance of Genome Resources | |||
| Joubert syndrome 17 | CPLANE1* | Cplane1* | 1 model | Alliance of Genome Resources | |||
| Joubert syndrome 26 | KATNIP* | Katnip* | 1 model | Alliance of Genome Resources | |||
| Joubert syndrome 3 | AHI1* | Ahi1* | 1 model | Alliance of Genome Resources | |||
| Joubert syndrome 5 | CEP290* | Cep290* | 2 models | Alliance of Genome Resources | |||
| Joubert syndrome 6 | TMEM67* | Tmem67* | 1 model | Alliance of Genome Resources | |||
| Joubert syndrome 7 | RPGRIP1L* | Rpgrip1l* | 1 model | Alliance of Genome Resources | |||
| juvenile myoclonic epilepsy | EFHC1* | Efhc1* | 2 models | Alliance of Genome Resources | |||
| juvenile spinal muscular atrophy | SMN1*, SMN2* | Smn1* | 2 models | Alliance of Genome Resources | |||
| Kufor-Rakeb syndrome | ATP13A2* | Atp13a2* | 1 model | Alliance of Genome Resources | |||
| L-2-hydroxyglutaric aciduria | L2HGDH* | L2hgdh* | 1 model | Alliance of Genome Resources | |||
| leukoencephalopathy with vanishing white matter | EIF2B5* | Eif2b5* | 7 models | Alliance of Genome Resources | |||
| MASA syndrome | L1CAM* | L1cam* | 1 model | Alliance of Genome Resources | |||
| Mast syndrome | SPG21* | Spg21* | 1 model | Alliance of Genome Resources | |||
| megalencephalic leukoencephalopathy with subcortical cysts 1 | MLC1* | Mlc1* | 1 model | Alliance of Genome Resources | |||
| multiple sclerosis | PRF1* | Prf1* | 1 model | Alliance of Genome Resources | |||
| multiple sclerosis | TNF* | Tnf* | 2 models | Alliance of Genome Resources | |||
| myoclonic dystonia 11 | SGCE* | Sgce* | 2 models | Alliance of Genome Resources | |||
| neurodegeneration with brain iron accumulation 2a | PLA2G6* | Pla2g6* | 4 models | Alliance of Genome Resources | |||
| neurodegeneration with brain iron accumulation 5 | WDR45* | Wdr45* | 2 models | Alliance of Genome Resources | |||
| neurodegeneration with brain iron accumulation 6 | COASY* | Coasy* | 1 model | Alliance of Genome Resources | |||
| neurodevelopmental disorder with involuntary movements | GNAO1* | Gnao1* | 1 model | Alliance of Genome Resources | |||
| normal pressure hydrocephalus | CFAP43* | Cfap43* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | EN1* | En1* | 3 models | Alliance of Genome Resources | |||
| Parkinson's disease | NR4A2* | Nr4a2* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | PPARGC1A* | Ppargc1a* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | TFAM* | Tfam* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | VPS35* | Vps35* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease 1 | SNCA* | Snca* | 6 models | Alliance of Genome Resources | |||
| Parkinson's disease 14 | PLA2G6* | Pla2g6* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease 17 | VPS35* | Vps35* | 2 models | Alliance of Genome Resources | |||
| Parkinson's disease 2 | PRKN* | Prkn* | 9 models | Alliance of Genome Resources | |||
| Parkinson's disease 4 | SNCA* | Snca* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease 6 | PINK1* | Pink1* | 4 models | Alliance of Genome Resources | |||
| Parkinson's disease 7 | PARK7* | Park7* | 4 models | Alliance of Genome Resources | |||
| Parkinson's disease 8 | LRRK2* | Lrrk2* | 1 model | Alliance of Genome Resources | |||
| paroxysmal nonkinesigenic dyskinesia 1 | PNKD* | Pnkd* | 2 models | Alliance of Genome Resources | |||
| Pelizaeus-Merzbacher disease | PLP1* | Plp1* | 8 models | Alliance of Genome Resources | |||
| pontocerebellar hypoplasia type 10 | CLP1* | Clp1* | 3 models | Alliance of Genome Resources | |||
| pontocerebellar hypoplasia type 14 | PPIL1* | Ppil1* | 2 models | Alliance of Genome Resources | |||
| progressive myoclonus epilepsy 1B | PRICKLE1* | Prickle1* | 1 model | Alliance of Genome Resources | |||
| spinocerebellar ataxia type 1 | ATXN1* | Atxn1* | 1 model | Alliance of Genome Resources | |||
| spinocerebellar ataxia type 14 | PRKCG* | Prkcg* | 2 models | Alliance of Genome Resources | |||
| spinocerebellar ataxia type 17 | TBP* | Tbp* | 1 model | Alliance of Genome Resources | |||
| spinocerebellar ataxia type 2 | ATXN2* | Atxn2* | 1 model | Alliance of Genome Resources | |||
| spinocerebellar ataxia type 28 | AFG3L2* | Afg3l2* | 1 model | Alliance of Genome Resources | |||
| spinocerebellar ataxia type 5 | SPTBN2* | Sptbn2* | 2 models | Alliance of Genome Resources | |||
| spinocerebellar ataxia type 6 | CACNA1A* | Cacna1a* | 3 models | Alliance of Genome Resources | |||
| spinocerebellar ataxia type 7 | ATXN7* | Atxn7* | 5 models | Alliance of Genome Resources | |||
| spinocerebellar ataxia with axonal neuropathy 1 | TDP1* | Tdp1* | 1 model | Alliance of Genome Resources | |||
| torsion dystonia 1 | TOR1A* | Tor1a* | 4 models | Alliance of Genome Resources | |||
| torsion dystonia 6 | THAP1* | Thap1* | 2 models | Alliance of Genome Resources | |||
| Troyer syndrome | SPART* | Spart* | 1 model | Alliance of Genome Resources | |||
| Unverricht-Lundborg syndrome | CSTB* | Cstb* | 1 model | Alliance of Genome Resources | |||
| Werdnig-Hoffmann disease | SMN1*, SMN2 | Smn1* | 17 models | Alliance of Genome Resources | |||
| X-linked distal spinal muscular atrophy 3 | ATP7A* | Atp7a* | 2 models | Alliance of Genome Resources | |||
| | Alzheimer's disease | PLCB1 | Plcb1* | 1 model | Alliance of Genome Resources | ||
| Alzheimer's disease | PIN1 | Pin1*, Pin1rt1 | 2 models | Alliance of Genome Resources | |||
| Alzheimer's disease | IL33 | Il33* | 1 model | Alliance of Genome Resources | |||
| Alzheimer's disease | CAV1 | Cav1* | 1 model | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis | STMN2 | Stmn2* | 2 models | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis | PSMC4 | Psmc4* | 1 model | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis | EPG5 | Epg5* | 1 model | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis | ADARB1 | Adarb1* | 1 model | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis | ZNF106 | Zfp106* | 1 model | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis type 1 | VPS54 | Vps54* | 1 model | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis type 1 | VEGFA | Vegfa* | 1 model | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis type 1 | SOD2 | Sod2* | 1 model | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis type 1 | SNCG | Sncg* | 1 model | Alliance of Genome Resources | |||
| arteriovenous malformations of the brain | ACVRL1 | Acvrl1* | 1 model | Alliance of Genome Resources | |||
| arteriovenous malformations of the brain | NOTCH4 | Notch4* | 1 model | Alliance of Genome Resources | |||
| brain disease | PTEN | Pten* | 1 model | Alliance of Genome Resources | |||
| Canavan disease | SOD2 | Sod2* | 1 model | Alliance of Genome Resources | |||
| cerebellar ataxia | CACNA1A | Cacna1a* | 1 model | Alliance of Genome Resources | |||
| cerebellar disease | ZNF423 | Zfp423* | 1 model | Alliance of Genome Resources | |||
| Charlevoix-Saguenay spastic ataxia | ANKFY1 | Ankfy1* | 1 model | Alliance of Genome Resources | |||
| childhood electroclinical syndrome | CACNA1A | Cacna1a* | 1 model | Alliance of Genome Resources | |||
| Dandy-Walker syndrome | ZNF423 | Zfp423* | 1 model | Alliance of Genome Resources | |||
| Dandy-Walker syndrome | ZIC4 | Zic4* | 1 model | Alliance of Genome Resources | |||
| early infantile epileptic encephalopathy | SCN8A | Scn8a* | 1 model | Alliance of Genome Resources | |||
| early infantile epileptic encephalopathy | GOT2 | Got2* | 2 models | Alliance of Genome Resources | |||
| early infantile epileptic encephalopathy | ARX | Arx* | 7 models | Alliance of Genome Resources | |||
| encephalomyelitis | IKZF4 | Ikzf4* | 1 model | Alliance of Genome Resources | |||
| epilepsy | ATP6V1B2 | Atp6v1b2* | 1 model | Alliance of Genome Resources | |||
| epilepsy | SYN2 | Syn2* | 2 models | Alliance of Genome Resources | |||
| epilepsy | SLC12A5 | Slc12a5* | 1 model | Alliance of Genome Resources | |||
| epilepsy | SCN8A | Scn8a* | 1 model | Alliance of Genome Resources | |||
| epilepsy | SCAMP5 | Scamp5* | 1 model | Alliance of Genome Resources | |||
| epilepsy | KCNA1 | Kcna1* | 1 model | Alliance of Genome Resources | |||
| epilepsy | GAD2 | Gad2* | 1 model | Alliance of Genome Resources | |||
| epilepsy | CDYL | Cdyl* | 1 model | Alliance of Genome Resources | |||
| epilepsy | CACNA2D2 | Cacna2d2* | 1 model | Alliance of Genome Resources | |||
| epilepsy | C1QA | C1qa* | 1 model | Alliance of Genome Resources | |||
| epilepsy | BSN | Bsn* | 1 model | Alliance of Genome Resources | |||
| epilepsy | ALDH5A1 | Aldh5a1* | 1 model | Alliance of Genome Resources | |||
| familial hemiplegic migraine | CACNA1A | Cacna1a* | 5 models | Alliance of Genome Resources | |||
| focal dystonia | TOR1A | Tor1a* | 1 model | Alliance of Genome Resources | |||
| frontotemporal dementia | VCP | Vcp* | 1 model | Alliance of Genome Resources | |||
| frontotemporal dementia | TREM2 | Trem2* | 1 model | Alliance of Genome Resources | |||
| frontotemporal dementia | TARDBP | Tardbp* | 2 models | Alliance of Genome Resources | |||
| generalized dystonia | CACNA1A | Cacna1a* | 2 models | Alliance of Genome Resources | |||
| generalized epilepsy with febrile seizures plus | SCN1B | Scn1b* | 1 model | Alliance of Genome Resources | |||
| generalized epilepsy with febrile seizures plus | GABRG2 | Gabrg2* | 1 model | Alliance of Genome Resources | |||
| glioblastoma | TP53 | Trp53* | 2 models | Alliance of Genome Resources | |||
| Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | TARDBP | Tardbp* | 1 model | Alliance of Genome Resources | |||
| hereditary ataxia | SCYL1 | Scyl1* | 1 model | Alliance of Genome Resources | |||
| hereditary ataxia | RNF170 | Rnf170* | 1 model | Alliance of Genome Resources | |||
| hereditary spastic paraplegia | BORCS7 | Borcs7* | 1 model | Alliance of Genome Resources | |||
| Huntington's disease | PPARD | Ppard* | 1 model | Alliance of Genome Resources | |||
| Huntington's disease | ZDHHC13 | Zdhhc13* | 1 model | Alliance of Genome Resources | |||
| Huntington's disease | ZDHHC17 | Zdhhc17* | 1 model | Alliance of Genome Resources | |||
| hydrocephalus | ULK4 | Ulk4* | 1 model | Alliance of Genome Resources | |||
| hydrocephalus | SOX3 | Sox3* | 1 model | Alliance of Genome Resources | |||
| hydrocephalus | NME7 | Nme7* | 1 model | Alliance of Genome Resources | |||
| hydrocephalus | NME5 | Nme5* | 1 model | Alliance of Genome Resources | |||
| hydrocephalus | MBOAT7 | Mboat7* | 1 model | Alliance of Genome Resources | |||
| hydrocephalus | KIF27 | Kif27* | 1 model | Alliance of Genome Resources | |||
| hydrocephalus | HYDIN | Hydin* | 1 model | Alliance of Genome Resources | |||
| hydrocephalus | E2F5 | E2f5* | 1 model | Alliance of Genome Resources | |||
| hydrocephalus | DPCD | Dpcd* | 1 model | Alliance of Genome Resources | |||
| hydrocephalus | CELSR2 | Celsr2* | 1 model | Alliance of Genome Resources | |||
| hydrocephalus | POMK | Pomk* | 1 model | Alliance of Genome Resources | |||
| hydrocephalus | STK36 | Stk36* | 1 model | Alliance of Genome Resources | |||
| hydrocephalus | AK7 | Ak7* | 1 model | Alliance of Genome Resources | |||
| hydrocephalus | AK8 | Ak8* | 1 model | Alliance of Genome Resources | |||
| hydrocephalus | CCDC85C | Ccdc85c* | 1 model | Alliance of Genome Resources | |||
| hydrocephalus | CCDC39 | Ccdc39* | 1 model | Alliance of Genome Resources | |||
| hydrocephalus | ADD1 | Add1* | 1 model | Alliance of Genome Resources | |||
| idiopathic generalized epilepsy | GABRA1 | Gabra1* | 3 models | Alliance of Genome Resources | |||
| idiopathic generalized epilepsy | DNM1 | Dnm1* | 2 models | Alliance of Genome Resources | |||
| Joubert syndrome | ZIC1 | Zic1* | 1 model | Alliance of Genome Resources | |||
| Lafora disease | NHLRC1 | Nhlrc1* | 3 models | Alliance of Genome Resources | |||
| Lafora disease | EPM2A | Epm2a* | 1 model | Alliance of Genome Resources | |||
| Lennox-Gastaut syndrome | DGKD | Dgkd* | 1 model | Alliance of Genome Resources | |||
| leukodystrophy | CLCN2 | Clcn2* | 1 model | Alliance of Genome Resources | |||
| leukoencephalopathy with vanishing white matter | EIF2B4 | Eif2b4* | 4 models | Alliance of Genome Resources | |||
| malignant astrocytoma | HRAS | Hras* | 1 model | Alliance of Genome Resources | |||
| medulloblastoma | SMO | Smo* | 8 models | Alliance of Genome Resources | |||
| medulloblastoma | IFNG | Ifng* | 2 models | Alliance of Genome Resources | |||
| medulloblastoma | PTCH1 | Ptch1* | 12 models | Alliance of Genome Resources | |||
| megalencephalic leukoencephalopathy with subcortical cysts | HEPACAM | Hepacam* | 1 model | Alliance of Genome Resources | |||
| motor neuron disease | RHOT1 | Rhot1* | 1 model | Alliance of Genome Resources | |||
| movement disease | EFNB3 | Efnb3* | 1 model | Alliance of Genome Resources | |||
| multiple sclerosis | LRCH1 | Lrch1* | 1 model | Alliance of Genome Resources | |||
| neuroaxonal dystrophy | BORCS7 | Borcs7* | 1 model | Alliance of Genome Resources | |||
| neurodegeneration with brain iron accumulation 2a | nad* | 1 model | |||||
| neurodegeneration with brain iron accumulation 2a | gnd* | 1 model | |||||
| neurodegeneration with brain iron accumulation 2a | inad* | 1 model | |||||
| neurodegenerative disease | HPDL | Hpdl* | 1 model | Alliance of Genome Resources | |||
| neurodegenerative disease | CLEC16A | Clec16a* | 1 model | Alliance of Genome Resources | |||
| normal pressure hydrocephalus | AK9 | Ak9* | 1 model | Alliance of Genome Resources | |||
| normal pressure hydrocephalus | CWH43 | Cwh43* | 3 models | Alliance of Genome Resources | |||
| normal pressure hydrocephalus | p23-ST1* | 1 model | |||||
| obstructive hydrocephalus | MYO9A | Myo9a* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | ADCY5 | Adcy5* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | ADH7 | Adh7* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | ATG7 | Atg7* | 2 models | Alliance of Genome Resources | |||
| Parkinson's disease | COX10 | Cox10* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | DRD2 | Drd2* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | KCNN2 | Kcnn2* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | MINAR2 | Minar2* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | nm3* | 1 model | |||||
| Parkinson's disease | PITX3 | Pitx3* | 3 models | Alliance of Genome Resources | |||
| Parkinson's disease | RRN3, RRN3P1, RRN3P2 | Rrn3* | 2 models | Alliance of Genome Resources | |||
| Parkinson's disease | SPR | Spr* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | TWNK | Twnk* | 1 model | Alliance of Genome Resources | |||
| porencephaly | COL4A1 | Col4a1* | 1 model | Alliance of Genome Resources | |||
| progressive myoclonus epilepsy | SCARB2 | Scarb2* | 1 model | Alliance of Genome Resources | |||
| pyridoxine-dependent epilepsy | ALDH7A1 | Aldh7a1* | 1 model | Alliance of Genome Resources | |||
| restless legs syndrome | DRD3 | Drd3* | 1 model | Alliance of Genome Resources | |||
| restless legs syndrome | BTBD9 | Btbd9* | 4 models | Alliance of Genome Resources | |||
| restless legs syndrome | MEIS1 | Meis1* | 1 model | Alliance of Genome Resources | |||
| spinocerebellar ataxia type 27 | FGF14 | Fgf14* | 1 model | Alliance of Genome Resources | |||
| Stiff-Person syndrome | TRAK1 | Trak1* | 1 model | Alliance of Genome Resources | |||
| temporal lobe epilepsy | GLUL | Glul* | 1 model | Alliance of Genome Resources | |||
| temporal lobe epilepsy | SLC32A1 | Slc32a1* | 1 model | Alliance of Genome Resources | |||
| temporal lobe epilepsy | KCNA1 | Kcna1* | 1 model | Alliance of Genome Resources | |||
| tropical spastic paraparesis | ZEB1 | Zeb1* | 1 model | Alliance of Genome Resources | |||
| Werdnig-Hoffmann disease | VPS54 | Vps54* | 1 model | Alliance of Genome Resources | |||
| | acute disseminated encephalomyelitis | HLA-DRB1*, HLA-DRB5*, HLA-DRB3, HLA-DRB4 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | |||
| acute disseminated encephalomyelitis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| adult-onset leukoencephalopathy with axonal spheroids and pigmented glia | CSF1R* | Csf1r | Alliance of Genome Resources | ||||
| adult spinal muscular atrophy | SMN1*, SMN2 | Smn1 | Alliance of Genome Resources | ||||
| alternating hemiplegia of childhood | ATP1A2* | Atp1a2 | Alliance of Genome Resources | ||||
| alveolar echinococcosis | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| alveolar echinococcosis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | SERPINE2* | Serpine2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | S100B* | S100b | Alliance of Genome Resources | ||||
| Alzheimer's disease | RCAN1* | Rcan1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | PSEN2* | Psen2 | 3 models | Alliance of Genome Resources | |||
| Alzheimer's disease | PPP3R1* | Ppp3r1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | PPP2R2B* | Ppp2r2b | Alliance of Genome Resources | ||||
| Alzheimer's disease | PPARG* | Pparg | Alliance of Genome Resources | ||||
| Alzheimer's disease | PPARA* | Ppara | Alliance of Genome Resources | ||||
| Alzheimer's disease | PON3* | Pon3 | Alliance of Genome Resources | ||||
| Alzheimer's disease | PON2* | Pon2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | PON1* | Pon1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | PNMT* | Pnmt | Alliance of Genome Resources | ||||
| Alzheimer's disease | PIK3R1* | Pik3r1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | PCK1* | Pck1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | PARP1* | Parp1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | NTRK2* | Ntrk2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | NTRK1* | Ntrk1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | NTF3* | Ntf3 | Alliance of Genome Resources | ||||
| Alzheimer's disease | NOS3* | Nos3 | Alliance of Genome Resources | ||||
| Alzheimer's disease | NOS1* | Nos1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | NGFR* | Ngfr | Alliance of Genome Resources | ||||
| Alzheimer's disease | NFE2L2* | Nfe2l2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | NEFM* | Nefm | Alliance of Genome Resources | ||||
| Alzheimer's disease | NECTIN2* | Nectin2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | NCSTN* | Ncstn | Alliance of Genome Resources | ||||
| Alzheimer's disease | NCF2* | Ncf2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | ND2* | mt-Nd2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | MT3* | Mt3 | Alliance of Genome Resources | ||||
| Alzheimer's disease | MCM2* | Mcm2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | MAPT* | Mapt | 2 models | Alliance of Genome Resources | |||
| Alzheimer's disease | MAOB* | Maob | Alliance of Genome Resources | ||||
| Alzheimer's disease | ADAM17* | Adam17 | Alliance of Genome Resources | ||||
| Alzheimer's disease | ADRA1A* | Adra1a | Alliance of Genome Resources | ||||
| Alzheimer's disease | ADRB3* | Adrb3 | Alliance of Genome Resources | ||||
| Alzheimer's disease | AGER* | Ager | Alliance of Genome Resources | ||||
| Alzheimer's disease | AGTR1* | Agtr1a, Agtr1b | Alliance of Genome Resources | ||||
| Alzheimer's disease | ALDH2* | Aldh2 | 1 model | Alliance of Genome Resources | |||
| Alzheimer's disease | MAOA* | Maoa | Alliance of Genome Resources | ||||
| Alzheimer's disease | LRPAP1* | Lrpap1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | LRP8* | Lrp8 | Alliance of Genome Resources | ||||
| Alzheimer's disease | LPL* | Lpl | Alliance of Genome Resources | ||||
| Alzheimer's disease | LIPC* | Lipc | Alliance of Genome Resources | ||||
| Alzheimer's disease | LDLR* | Ldlr | 1 model | Alliance of Genome Resources | |||
| Alzheimer's disease | KLK6* | Klk6 | Alliance of Genome Resources | ||||
| Alzheimer's disease | KLC1* | Klc1 | 1 model | Alliance of Genome Resources | |||
| Alzheimer's disease | KCNMA1* | Kcnma1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | APBB1* | Apbb1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | TAP2* | Tap2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | IRS1* | Irs1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | IREB2* | Ireb2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | IL10* | Il10 | Alliance of Genome Resources | ||||
| Alzheimer's disease | IL6R* | Il6ra | Alliance of Genome Resources | ||||
| Alzheimer's disease | IL4* | Il4 | Alliance of Genome Resources | ||||
| Alzheimer's disease | IL2* | Il2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | IL1B* | Il1b | Alliance of Genome Resources | ||||
| Alzheimer's disease | IL1A* | Il1a | Alliance of Genome Resources | ||||
| Alzheimer's disease | XRN1* | Xrn1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | WT1* | Wt1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | VLDLR* | Vldlr | Alliance of Genome Resources | ||||
| Alzheimer's disease | IGFBP3* | Igfbp3 | Alliance of Genome Resources | ||||
| Alzheimer's disease | IGF1* | Igf1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | ICAM1* | Icam1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | HTR6* | Htr6 | Alliance of Genome Resources | ||||
| Alzheimer's disease | HSPA1A*, HSPA1B* | Hspa1a, Hspa1b | Alliance of Genome Resources | ||||
| Alzheimer's disease | HMGCR* | Hmgcr | Alliance of Genome Resources | ||||
| Alzheimer's disease | HFE* | Hfe | Alliance of Genome Resources | ||||
| Alzheimer's disease | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | CASP7* | Casp7 | Alliance of Genome Resources | ||||
| Alzheimer's disease | C2* | C2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | BDNF* | Bdnf | Alliance of Genome Resources | ||||
| Alzheimer's disease | BCHE* | Bche | Alliance of Genome Resources | ||||
| Alzheimer's disease | BACE2* | Bace2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | BACE1* | Bace1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | APOE* | Apoe | 4 models | Alliance of Genome Resources | |||
| Alzheimer's disease | ABAT* | Abat | Alliance of Genome Resources | ||||
| Alzheimer's disease | STAT3* | Stat3 | Alliance of Genome Resources | ||||
| Alzheimer's disease | ABCA1* | Abca1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | SORL1* | Sorl1 | 1 model | Alliance of Genome Resources | |||
| Alzheimer's disease | SOD2* | Sod2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | ACHE* | Ache | Alliance of Genome Resources | ||||
| Alzheimer's disease | SNCA* | Snca | Alliance of Genome Resources | ||||
| Alzheimer's disease | CDK5R1* | Cdk5r1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | CDK5* | Cdk5 | Alliance of Genome Resources | ||||
| Alzheimer's disease | TFAM* | Tfam | Alliance of Genome Resources | ||||
| Alzheimer's disease | APOC1* | Apoc1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | C3* | C3 | Alliance of Genome Resources | ||||
| Alzheimer's disease | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
| Alzheimer's disease | GSTO2* | Gsto2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | APBB2* | Apbb2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | GSTO1* | Gsto1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | A2M* | A2m | Alliance of Genome Resources | ||||
| Alzheimer's disease | GSTM3* | Gstm5 | Alliance of Genome Resources | ||||
| Alzheimer's disease | GSS* | Gss | Alliance of Genome Resources | ||||
| Alzheimer's disease | GSK3B* | Gsk3b | Alliance of Genome Resources | ||||
| Alzheimer's disease | VEGFA* | Vegfa | Alliance of Genome Resources | ||||
| Alzheimer's disease | GRN* | Grn | Alliance of Genome Resources | ||||
| Alzheimer's disease | GRIN2B* | Grin2b | Alliance of Genome Resources | ||||
| Alzheimer's disease | GLUL* | Glul | Alliance of Genome Resources | ||||
| Alzheimer's disease | GCG* | Gcg | Alliance of Genome Resources | ||||
| Alzheimer's disease | GAPDHS* | Gapdhs | Alliance of Genome Resources | ||||
| Alzheimer's disease | GAPDH* | Gapdh, Gapdh-ps15, Gapdhrt, Gapdhrt2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | FYN* | Fyn | Alliance of Genome Resources | ||||
| Alzheimer's disease | FAS* | Fas | Alliance of Genome Resources | ||||
| Alzheimer's disease | ESR2* | Esr2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | UQCRC1* | Uqcrc1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | UCHL1* | Uchl1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | TTR* | Ttr | Alliance of Genome Resources | ||||
| Alzheimer's disease | TPH1* | Tph1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | TNF* | Tnf | Alliance of Genome Resources | ||||
| Alzheimer's disease | ESR1* | Esr1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | EPO* | Epo | Alliance of Genome Resources | ||||
| Alzheimer's disease | ENO1* | Eno1, Eno1b | Alliance of Genome Resources | ||||
| Alzheimer's disease | EIF2S1* | Eif2s1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | EIF2AK2* | Eif2ak2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | TLR4* | Tlr4 | Alliance of Genome Resources | ||||
| Alzheimer's disease | ECE1* | Ece1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | DLST* | Dlst | Alliance of Genome Resources | ||||
| Alzheimer's disease | CYP46A1* | Cyp46a1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | CYP19A1* | Cyp19a1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | CTSD* | Ctsd | Alliance of Genome Resources | ||||
| Alzheimer's disease | APOA1* | Apoa1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | APOA4* | Apoa4 | 1 model | Alliance of Genome Resources | |||
| Alzheimer's disease | CLOCK* | Clock | Alliance of Genome Resources | ||||
| Alzheimer's disease | CHAT* | Chat | Alliance of Genome Resources | ||||
| Alzheimer's disease 1 | APP* | App | Alliance of Genome Resources | ||||
| Alzheimer's disease 1 | MPO* | Mpo | Alliance of Genome Resources | ||||
| Alzheimer's disease 1 | PLAU* | Plau | Alliance of Genome Resources | ||||
| Alzheimer's disease 18 | ADAM10* | Adam10 | Alliance of Genome Resources | ||||
| Alzheimer's disease 2 | APOE* | Apoe | Alliance of Genome Resources | ||||
| Alzheimer's disease 3 | APOE* | Apoe | Alliance of Genome Resources | ||||
| Alzheimer's disease 4 | PSEN2* | Psen2 | 1 model | Alliance of Genome Resources | |||
| Alzheimer's disease 9 | ABCA7* | Abca7 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | VDR* | Vdr | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | VAPB* | Vapb | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | UNC13A* | Unc13a | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | UBQLN2* | Ubqln2 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | TXNRD1* | Txnrd1 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | TFAM* | Tfam | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | TARDBP* | Tardbp | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | SOD1* | Sod1 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | SLC11A2* | Slc11a2 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | PPARGC1A* | Ppargc1a | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | PON3* | Pon3 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | OPTN* | Optn | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | NRG1* | Nrg1 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | NEFL* | Nefl | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | NEFH* | Nefh | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | ITPR2* | Itpr2 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | HMGB1* | Hmgb1 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | GSK3B* | Gsk3b | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | GSK3A* | Gsk3a | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | GRN* | Grn | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | GOT1* | Got1 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | FUS* | Fus | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | DPP6* | Dpp6 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | CHMP2B* | Chmp2b | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | CCS* | Ccs | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | APOE* | Apoe | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | AOX1* | Aox1 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | ANG* | Ang, Ang2, Ang3, Ang4, Ang5, Ang6 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | PON2* | Pon2 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | ALS2* | Als2 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis-parkinsonism/dementia complex 1 | TRPM7* | Trpm7 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 1 | DCTN1* | Dctn1 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 1 | NEFH* | Nefh | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 1 | PRPH* | Prph | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 11 | FIG4* | Fig4 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 12 | OPTN* | Optn | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 15 | UBQLN2* | Ubqln2 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 16 | SIGMAR1* | Sigmar1 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 18 | PFN1* | Pfn1 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 19 | ERBB4* | Erbb4 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 2 | ALS2* | Als2 | 3 "NOT" models | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis type 20 | HNRNPA1*, HNRNPA1L2 | Hnrnpa1, Hnrnpa1l2-ps2 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 22 | TUBA4A* | Tuba4a | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 23 | ANXA11* | Anxa11 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 24 | NEK1* | Nek1 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 25 | KIF5A* | Kif5a | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 26 | TIA1* | Tia1 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 28 | LRP12* | Lrp12 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 5 | SPG11* | Spg11 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 8 | VAPB* | Vapb | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 9 | ANG* | Ang, Ang2, Ang3, Ang4, Ang5, Ang6 | Alliance of Genome Resources | ||||
| arteriovenous malformations of the brain | IL6* | Il6 | Alliance of Genome Resources | ||||
| astroblastoma | PIK3R1* | Pik3r1 | Alliance of Genome Resources | ||||
| ataxia-oculomotor apraxia type 4 | PNKP* | Pnkp | Alliance of Genome Resources | ||||
| ataxia telangiectasia | HDAC4* | Hdac4 | Alliance of Genome Resources | ||||
| ataxia telangiectasia | BIK* | Bik | Alliance of Genome Resources | ||||
| ataxia telangiectasia | IL2* | Il2 | Alliance of Genome Resources | ||||
| ataxia telangiectasia | BAX* | Bax | Alliance of Genome Resources | ||||
| ataxia telangiectasia | BAK1* | Bak1 | Alliance of Genome Resources | ||||
| ataxia telangiectasia | IFNG* | Ifng | Alliance of Genome Resources | ||||
| ataxia-telangiectasia-like disorder-1 | MRE11* | Mre11a | Alliance of Genome Resources | ||||
| ataxia-telangiectasia-like disorder-2 | PCNA* | Pcna | Alliance of Genome Resources | ||||
| ataxia with oculomotor apraxia type 1 | APTX* | Aptx | Alliance of Genome Resources | ||||
| ataxia with oculomotor apraxia type 3 | PIK3R5* | Pik3r5 | Alliance of Genome Resources | ||||
| autosomal dominant adult-onset proximal spinal muscular atrophy | VAPB* | Vapb | Alliance of Genome Resources | ||||
| autosomal dominant cerebellar ataxia | SAMD9L* | Samd9l | Alliance of Genome Resources | ||||
| autosomal dominant cerebellar ataxia | NPTX1* | Nptx1 | Alliance of Genome Resources | ||||
| autosomal dominant cerebellar ataxia | FGF14* | Fgf14 | Alliance of Genome Resources | ||||
| autosomal dominant cerebellar ataxia, deafness and narcolepsy | DNMT1* | Dnmt1 | Alliance of Genome Resources | ||||
| autosomal dominant distal hereditary motor neuronopathy 10 | EMILIN1* | Emilin1 | Alliance of Genome Resources | ||||
| autosomal dominant distal hereditary motor neuronopathy 11 | SPTAN1* | Sptan1 | Alliance of Genome Resources | ||||
| autosomal dominant distal hereditary motor neuronopathy 12 | REEP1* | Reep1 | Alliance of Genome Resources | ||||
| autosomal dominant distal hereditary motor neuronopathy 13 | BSCL2* | Bscl2 | Alliance of Genome Resources | ||||
| autosomal dominant distal hereditary motor neuronopathy 14 | DCTN1* | Dctn1 | Alliance of Genome Resources | ||||
| autosomal dominant distal hereditary motor neuronopathy 3 | HSPB1* | Hspb1 | Alliance of Genome Resources | ||||
| autosomal dominant distal hereditary motor neuronopathy 4 | HSPB3* | Hspb3 | Alliance of Genome Resources | ||||
| autosomal dominant distal hereditary motor neuronopathy 5 | GARS1* | Gars1 | Alliance of Genome Resources | ||||
| autosomal dominant distal hereditary motor neuronopathy 6 | FBXO38* | Fbxo38 | Alliance of Genome Resources | ||||
| autosomal dominant distal hereditary motor neuronopathy 7 | SLC5A7* | Slc5a7 | Alliance of Genome Resources | ||||
| autosomal dominant distal hereditary motor neuronopathy 8 | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
| autosomal dominant distal hereditary motor neuronopathy 9 | WARS1* | Wars1 | Alliance of Genome Resources | ||||
| autosomal dominant nocturnal frontal lobe epilepsy | CHRNB2* | Chrnb2 | Alliance of Genome Resources | ||||
| autosomal dominant nocturnal frontal lobe epilepsy 1 | CHRNA4* | Chrna4 | 1 "NOT" model | Alliance of Genome Resources | |||
| autosomal dominant nocturnal frontal lobe epilepsy 4 | CHRNA2* | Chrna2 | Alliance of Genome Resources | ||||
| autosomal dominant nocturnal frontal lobe epilepsy 5 | KCNT1* | Kcnt1 | Alliance of Genome Resources | ||||
| autosomal dominant sensory ataxia 1 | RNF170* | Rnf170 | Alliance of Genome Resources | ||||
| autosomal recessive distal hereditary motor neuronopathy 10 | VRK1* | Vrk1 | Alliance of Genome Resources | ||||
| autosomal recessive distal hereditary motor neuronopathy 2 | SIGMAR1* | Sigmar1 | Alliance of Genome Resources | ||||
| autosomal recessive distal hereditary motor neuronopathy 4 | PLEKHG5* | Plekhg5 | Alliance of Genome Resources | ||||
| autosomal recessive distal hereditary motor neuronopathy 5 | DNAJB2* | Dnajb2 | Alliance of Genome Resources | ||||
| autosomal recessive distal hereditary motor neuronopathy 6 | REEP1* | Reep1 | Alliance of Genome Resources | ||||
| autosomal recessive distal hereditary motor neuronopathy 7 | VWA1* | Vwa1 | Alliance of Genome Resources | ||||
| autosomal recessive distal hereditary motor neuronopathy 8 | SORD* | Sord | Alliance of Genome Resources | ||||
| autosomal recessive distal hereditary motor neuronopathy 9 | COQ7* | Coq7 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 10 | ANO10* | Ano10 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 11 | SYT14* | Syt14 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 14 | SPTBN2* | Sptbn2 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 15 | RUBCN* | Rubcn | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 17 | CWF19L1* | Cwf19l1 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 19 | SLC9A1* | Slc9a1 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 2 | PMPCA* | Pmpca | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 20 | SNX14* | Snx14 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 21 | SCYL1* | Scyl1 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 22 | VWA3B* | Vwa3b | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 23 | TDP2* | Tdp2 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 24 | UBA5* | Uba5 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 25 | ATG5* | Atg5 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 26 | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 27 | GDAP2* | Gdap2 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 28 | THG1L* | Thg1l | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 29 | VPS41* | Vps41 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 30 | PITRM1* | Pitrm1 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 31 | ATG7* | Atg7 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 32 | PRDX3* | Prdx3 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 33 | RNU12* | ||||||
| autosomal recessive spinocerebellar ataxia 4 | VPS13D* | Vps13d | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 7 | TPP1* | Tpp1 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 8 | SYNE1* | Syne1 | Alliance of Genome Resources | ||||
| bacterial meningitis | MMP9* | Mmp9 | Alliance of Genome Resources | ||||
| bacterial meningitis | PARP1* | Parp1 | Alliance of Genome Resources | ||||
| basal ganglia calcification | PDGFB* | Pdgfb | Alliance of Genome Resources | ||||
| basal ganglia calcification | MYORG* | Myorg | Alliance of Genome Resources | ||||
| basal ganglia calcification | XPR1* | Xpr1 | Alliance of Genome Resources | ||||
| basal ganglia calcification | JAM2* | Jam2 | Alliance of Genome Resources | ||||
| basal ganglia disease | FTL* | Ftl1, Ftl1-ps2, Ftl2-ps | Alliance of Genome Resources | ||||
| benign familial infantile seizures 2 | PRRT2* | Prrt2 | Alliance of Genome Resources | ||||
| benign familial infantile seizures 3 | SCN2A* | Scn2a | Alliance of Genome Resources | ||||
| benign familial infantile seizures 5 | SCN8A* | Scn8a | Alliance of Genome Resources | ||||
| benign familial infantile seizures 6 | CHRNA2* | Chrna2 | Alliance of Genome Resources | ||||
| benign neonatal seizures | ATP1A2* | Atp1a2 | Alliance of Genome Resources | ||||
| bilateral frontoparietal polymicrogyria | ADGRG1* | Adgrg1 | Alliance of Genome Resources | ||||
| bilateral parasagittal parieto-occipital polymicrogyria | FIG4* | Fig4 | Alliance of Genome Resources | ||||
| bilateral perisylvian polymicrogyria | ADGRG1* | Adgrg1 | Alliance of Genome Resources | ||||
| blepharospasm | DRD5* | Drd5 | Alliance of Genome Resources | ||||
| brain cancer | CCDC26* | ||||||
| brain cancer | TERT* | Tert | Alliance of Genome Resources | ||||
| brain cancer | CDKN2B-AS1* | ||||||
| brain disease | IRF3* | Irf3 | Alliance of Genome Resources | ||||
| brain disease | UNC93B1* | Unc93b1 | Alliance of Genome Resources | ||||
| brain disease | TRAF3* | Traf3 | Alliance of Genome Resources | ||||
| brain disease | TICAM1* | Ticam1 | Alliance of Genome Resources | ||||
| brain disease | TBK1* | Tbk1 | Alliance of Genome Resources | ||||
| brain disease | SNORA31* | ||||||
| brain disease | RANBP2*, RGPD1, RGPD2, RGPD3, RGPD4, RGPD5, RGPD6, RGPD8 | Ranbp2 | Alliance of Genome Resources | ||||
| brain disease | PPP2R2B* | Ppp2r2b | Alliance of Genome Resources | ||||
| brain disease | NUP214* | Nup214 | Alliance of Genome Resources | ||||
| brain disease | MFF* | Mff | Alliance of Genome Resources | ||||
| brain disease | DBR1* | Dbr1 | Alliance of Genome Resources | ||||
| brain disease | CPT2* | Cpt2 | Alliance of Genome Resources | ||||
| brain edema | SERPINF1* | Serpinf1 | Alliance of Genome Resources | ||||
| brain glioma | ADAM3A* | Adam3 | Alliance of Genome Resources | ||||
| brain glioma | PTPRB* | Ptprb | Alliance of Genome Resources | ||||
| brain glioma | XRCC3* | Xrcc3 | Alliance of Genome Resources | ||||
| brain glioma | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
| brain infarction | ADM* | Adm | Alliance of Genome Resources | ||||
| brain infarction | ALDH2* | Aldh2 | Alliance of Genome Resources | ||||
| brain infarction | CFH* | Cfh, Cfhr4 | Alliance of Genome Resources | ||||
| brain infarction | ALOX5AP* | Alox5ap | Alliance of Genome Resources | ||||
| brain infarction | CYP2R1* | Cyp2r1 | Alliance of Genome Resources | ||||
| brain infarction | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
| brain ischemia | PGF* | Pgf | Alliance of Genome Resources | ||||
| brain ischemia | MDK* | Mdk | Alliance of Genome Resources | ||||
| brain ischemia | IGF1* | Igf1 | Alliance of Genome Resources | ||||
| brain ischemia | HSPA1B*, HSPA1A | Hspa1a, Hspa1b | Alliance of Genome Resources | ||||
| brain ischemia | ANXA1* | Anxa1 | Alliance of Genome Resources | ||||
| brain ischemia | CSF3* | Csf3 | Alliance of Genome Resources | ||||
| brain ischemia | ANGPT1* | Angpt1 | Alliance of Genome Resources | ||||
| brain ischemia | FGF1* | Fgf1 | Alliance of Genome Resources | ||||
| brain ischemia | SELE* | Sele | Alliance of Genome Resources | ||||
| brain ischemia | PROZ* | Proz | Alliance of Genome Resources | ||||
| brain small vessel disease | NR1D1* | Nr1d1 | Alliance of Genome Resources | ||||
| brain small vessel disease | FGA* | Fga | Alliance of Genome Resources | ||||
| brain small vessel disease | FGG* | Fgg | Alliance of Genome Resources | ||||
| brain small vessel disease 2 | COL4A2* | Col4a2 | Alliance of Genome Resources | ||||
| brain small vessel disease 3 | COLGALT1* | Colgalt1 | Alliance of Genome Resources | ||||
| CADASIL | HTRA1* | Htra1 | Alliance of Genome Resources | ||||
| CADASIL 2 | HTRA1* | Htra1 | Alliance of Genome Resources | ||||
| carotid artery disease | GNB3* | Gnb3 | Alliance of Genome Resources | ||||
| carotid artery disease | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
| carotid artery disease | SREBF2* | Srebf2 | Alliance of Genome Resources | ||||
| carotid artery disease | SOD2* | Sod2 | Alliance of Genome Resources | ||||
| carotid artery disease | SELPLG* | Selplg | Alliance of Genome Resources | ||||
| carotid artery disease | PTGDS* | Ptgds | Alliance of Genome Resources | ||||
| carotid artery disease | UCP2* | Ucp2 | Alliance of Genome Resources | ||||
| carotid artery disease | PRL* | Prl | Alliance of Genome Resources | ||||
| carotid artery disease | LTA* | Lta | Alliance of Genome Resources | ||||
| carotid artery disease | MMP8* | Mmp8 | Alliance of Genome Resources | ||||
| carotid artery disease | CD14* | Cd14 | Alliance of Genome Resources | ||||
| carotid artery disease | CETP* | ||||||
| carotid artery disease | FGB* | Fgb | Alliance of Genome Resources | ||||
| carotid artery disease | MMP9* | Mmp9 | Alliance of Genome Resources | ||||
| carotid artery disease | AGT* | Agt | Alliance of Genome Resources | ||||
| carotid artery disease | TLR4* | Tlr4 | Alliance of Genome Resources | ||||
| carotid artery disease | XDH* | Xdh | Alliance of Genome Resources | ||||
| carotid artery disease | PPARG* | Pparg | Alliance of Genome Resources | ||||
| carotid artery disease | LUM* | Lum | Alliance of Genome Resources | ||||
| carotid artery disease | MMP1* | Mmp1a, Mmp1b | Alliance of Genome Resources | ||||
| carotid artery disease | MMP2* | Mmp2 | Alliance of Genome Resources | ||||
| carotid artery disease | AGTR1* | Agtr1a, Agtr1b | Alliance of Genome Resources | ||||
| carotid artery thrombosis | THBD* | Thbd | Alliance of Genome Resources | ||||
| carotid stenosis | F2* | F2 | Alliance of Genome Resources | ||||
| carotid stenosis | FABP2* | Fabp2 | Alliance of Genome Resources | ||||
| carotid stenosis | MMP1* | Mmp1a, Mmp1b | Alliance of Genome Resources | ||||
| carotid stenosis | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| carotid stenosis | PTGIS* | Ptgis | Alliance of Genome Resources | ||||
| carotid stenosis | MMP3* | Mmp3 | Alliance of Genome Resources | ||||
| carotid stenosis | MT2A*, MT1A, MT1B, MT1E, MT1F, MT1G, MT1H, MT1L, MT1M, MT1X | Mt1, Mt2 | Alliance of Genome Resources | ||||
| central nervous system cancer | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
| central nervous system cancer | XRCC3* | Xrcc3 | Alliance of Genome Resources | ||||
| central nervous system lymphoma | MYD88* | Myd88 | Alliance of Genome Resources | ||||
| central nervous system lymphoma | BTK* | Btk | Alliance of Genome Resources | ||||
| central nervous system lymphoma | CD79B* | Cd79b | Alliance of Genome Resources | ||||
| central nervous system lymphoma | IL10* | Il10 | Alliance of Genome Resources | ||||
| central nervous system vasculitis | HLA-A*, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
| cerebellar ataxia | ATCAY* | Atcay | Alliance of Genome Resources | ||||
| cerebellar ataxia | L2HGDH* | L2hgdh | Alliance of Genome Resources | ||||
| cerebellar ataxia | POLG* | Polg | Alliance of Genome Resources | ||||
| cerebellar ataxia | SYNE1* | Syne1 | Alliance of Genome Resources | ||||
| cerebellar ataxia | RPGRIP1L* | Rpgrip1l | Alliance of Genome Resources | ||||
| cerebellar ataxia type 41 | TRPC3* | Trpc3 | Alliance of Genome Resources | ||||
| cerebellar ataxia type 43 | MME* | Mme | Alliance of Genome Resources | ||||
| cerebellar ataxia type 47 | PUM1* | Pum1 | Alliance of Genome Resources | ||||
| cerebellar ataxia type 48 | STUB1* | Stub1 | Alliance of Genome Resources | ||||
| cerebral cavernous malformation | PON1* | Pon1 | Alliance of Genome Resources | ||||
| cerebral cavernous malformation | PIK3CA* | Pik3ca | Alliance of Genome Resources | ||||
| cerebral cavernous malformation 1 | PTGIS* | Ptgis | Alliance of Genome Resources | ||||
| cerebral cavernous malformation 1 | KRIT1* | Krit1 | Alliance of Genome Resources | ||||
| cerebral infarction | KCNN4* | Kcnn4 | Alliance of Genome Resources | ||||
| cerebral infarction | TYMS* | Tyms | Alliance of Genome Resources | ||||
| cerebral infarction | TOMM40* | Tomm40 | Alliance of Genome Resources | ||||
| cerebral infarction | TNF* | Tnf | Alliance of Genome Resources | ||||
| cerebral infarction | THBD* | Thbd | Alliance of Genome Resources | ||||
| cerebral infarction | TBXAS1* | Tbxas1 | Alliance of Genome Resources | ||||
| cerebral infarction | SERPING1* | Serping1 | Alliance of Genome Resources | ||||
| cerebral infarction | PTGIS* | Ptgis | Alliance of Genome Resources | ||||
| cerebral infarction | PROS1* | Pros1 | Alliance of Genome Resources | ||||
| cerebral infarction | PRKCH* | Prkch | Alliance of Genome Resources | ||||
| cerebral infarction | PON2* | Pon2 | Alliance of Genome Resources | ||||
| cerebral infarction | PON1* | Pon1 | Alliance of Genome Resources | ||||
| cerebral infarction | PHACTR1* | Phactr1 | Alliance of Genome Resources | ||||
| cerebral infarction | PDX1* | Pdx1 | Alliance of Genome Resources | ||||
| cerebral infarction | PARK7* | Park7 | Alliance of Genome Resources | ||||
| cerebral infarction | NR1H3* | Nr1h3 | Alliance of Genome Resources | ||||
| cerebral infarction | MYRF* | Myrf | Alliance of Genome Resources | ||||
| cerebral infarction | MTR* | Mtr | Alliance of Genome Resources | ||||
| cerebral infarction | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| cerebral infarction | LTA* | Lta | Alliance of Genome Resources | ||||
| cerebral infarction | ACE* | Ace | Alliance of Genome Resources | ||||
| cerebral infarction | AGXT2* | Agxt2 | Alliance of Genome Resources | ||||
| cerebral infarction | ALOX5AP* | Alox5ap | Alliance of Genome Resources | ||||
| cerebral infarction | APOA5* | Apoa5 | Alliance of Genome Resources | ||||
| cerebral infarction | APOE* | Apoe | Alliance of Genome Resources | ||||
| cerebral infarction | BHMT* | Bhmt, Bhmt1b | Alliance of Genome Resources | ||||
| cerebral infarction | CBS* | Cbs | Alliance of Genome Resources | ||||
| cerebral infarction | F2* | F2 | Alliance of Genome Resources | ||||
| cerebral infarction | F5* | F5 | Alliance of Genome Resources | ||||
| cerebral infarction | F7* | F7 | Alliance of Genome Resources | ||||
| cerebral infarction | FOLH1*, FOLH1B | Folh1 | Alliance of Genome Resources | ||||
| cerebral infarction | GCH1* | Gch1 | Alliance of Genome Resources | ||||
| cerebral infarction | GPX3* | Gpx3 | Alliance of Genome Resources | ||||
| cerebral infarction | GRIN1* | Grin1 | Alliance of Genome Resources | ||||
| cerebral infarction | HLA-A*, HLA-B*, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
| cerebral infarction | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| cerebral infarction | H19* | ||||||
| cerebral infarction | HNF1A* | Hnf1a | Alliance of Genome Resources | ||||
| cerebral infarction | IFNB1* | Ifnb1 | Alliance of Genome Resources | ||||
| cerebral infarction | ITGA9* | Itga9 | Alliance of Genome Resources | ||||
| cerebral infarction | LIPG* | Lipg | Alliance of Genome Resources | ||||
| cerebral infarction | KALRN* | Kalrn | Alliance of Genome Resources | ||||
| cerebral palsy | ALOX5AP* | Alox5ap | Alliance of Genome Resources | ||||
| cerebrovascular disease | SELE* | Sele | Alliance of Genome Resources | ||||
| cerebrovascular disease | AGT* | Agt | Alliance of Genome Resources | ||||
| cerebrovascular disease | AGTR1* | Agtr1a, Agtr1b | Alliance of Genome Resources | ||||
| cerebrovascular disease | APOE* | Apoe | Alliance of Genome Resources | ||||
| cerebrovascular disease | G6PD* | G6pd2, G6pdx | Alliance of Genome Resources | ||||
| cerebrovascular disease | GLCE* | Glce | Alliance of Genome Resources | ||||
| cerebrovascular disease | LMNA* | Lmna | Alliance of Genome Resources | ||||
| cerebrovascular disease | NR1H3* | Nr1h3 | Alliance of Genome Resources | ||||
| cerebrovascular disease | P2RY12* | P2ry12 | Alliance of Genome Resources | ||||
| cervical dystonia | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| childhood absence epilepsy | GABRB3* | Gabrb3 | Alliance of Genome Resources | ||||
| childhood absence epilepsy | CACNG3* | Cacng3 | Alliance of Genome Resources | ||||
| childhood absence epilepsy | SLC2A1* | Slc2a1 | Alliance of Genome Resources | ||||
| childhood absence epilepsy | NPY* | Npy | Alliance of Genome Resources | ||||
| childhood absence epilepsy | LGI4* | Lgi4 | Alliance of Genome Resources | ||||
| childhood absence epilepsy | CACNA1H* | Cacna1h | Alliance of Genome Resources | ||||
| childhood absence epilepsy | GRIK1* | Grik1 | Alliance of Genome Resources | ||||
| childhood absence epilepsy | GABRG2* | Gabrg2 | Alliance of Genome Resources | ||||
| childhood astrocytic tumor | RTEL1* | Rtel1 | Alliance of Genome Resources | ||||
| childhood-onset dystonia with optic atrophy and basal ganglia abnormalities | MECR* | Mecr | Alliance of Genome Resources | ||||
| childhood-onset neurodegeneration with brain atrophy | UBTF* | Ubtf | Alliance of Genome Resources | ||||
| chordoid glioma | PRKCA* | Prkca | Alliance of Genome Resources | ||||
| choreatic disease | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
| choreatic disease | VPS13A* | Vps13a | Alliance of Genome Resources | ||||
| choreatic disease | NKX2-1* | Nkx2-1 | Alliance of Genome Resources | ||||
| choreatic disease | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| choreatic disease | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| classic dopamine transporter deficiency syndrome | SLC6A3* | Slc6a3 | Alliance of Genome Resources | ||||
| complex cortical dysplasia with other brain malformations | KIF26A* | Kif26a | Alliance of Genome Resources | ||||
| complex cortical dysplasia with other brain malformations | CTNNA2* | Ctnna2 | Alliance of Genome Resources | ||||
| complex cortical dysplasia with other brain malformations | CAMSAP1* | Camsap1 | Alliance of Genome Resources | ||||
| complex cortical dysplasia with other brain malformations | APC2* | Apc2 | Alliance of Genome Resources | ||||
| complex cortical dysplasia with other brain malformations 1 | TUBB3* | Tubb3 | Alliance of Genome Resources | ||||
| complex cortical dysplasia with other brain malformations 2 | KIF5C* | Kif5c | Alliance of Genome Resources | ||||
| complex cortical dysplasia with other brain malformations 3 | KIF2A* | Kif2a | Alliance of Genome Resources | ||||
| complex cortical dysplasia with other brain malformations 5 | TUBB2A* | Tubb2a | Alliance of Genome Resources | ||||
| complex cortical dysplasia with other brain malformations 6 | TUBB* | Tubb5 | Alliance of Genome Resources | ||||
| congenital mirror movement disorder | DCC* | Dcc | Alliance of Genome Resources | ||||
| congenital mirror movement disorder | RAD51* | Rad51 | Alliance of Genome Resources | ||||
| congenital mirror movement disorder | DNAL4* | Dnal4 | Alliance of Genome Resources | ||||
| congenital mirror movement disorder | NTN1* | Ntn1 | Alliance of Genome Resources | ||||
| Creutzfeldt-Jakob disease | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| Creutzfeldt-Jakob disease | STX1A* | Stx1a | Alliance of Genome Resources | ||||
| Cryptococcal meningitis | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
| cystic echinococcosis | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| cystic echinococcosis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| cystic echinococcosis | TLR2* | Tlr2 | Alliance of Genome Resources | ||||
| demyelinating disease | MYC* | Bmyc, Myc | Alliance of Genome Resources | ||||
| demyelinating disease | KLK6* | Klk6 | Alliance of Genome Resources | ||||
| dentatorubral-pallidoluysian atrophy | ATN1* | Atn1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy | SNF8* | Snf8 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy | SLC32A1* | Slc32a1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy | KCNH5* | Kcnh5 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy | DEPDC5* | Depdc5 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy | SV2A* | Sv2a | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 1 | ARX* | Arx | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 100 | FBXO28* | Fbxo28 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 101 | GRIN1* | Grin1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 102 | SLC38A3* | Slc38a3 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 103 | KCNC2* | Kcnc2 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 104 | ATP6V0A1* | Atp6v0a1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 105 | HID1* | Hid1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 106 | UFSP2* | Ufsp2 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 107 | NAPB* | Napb | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 108 | MAST3* | Mast3 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 109 | FZR1* | Fzr1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 11 | SCN2A* | Scn2a | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 110 | CACNA2D1* | Cacna2d1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 116 | GLUL* | Glul | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 12 | PLCB1* | Plcb1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 13 | SCN8A* | Scn8a | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 15 | ST3GAL3* | St3gal3 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 18 | SZT2* | Szt2 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 19 | GABRA1* | Gabra1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 21 | NECAP1* | Necap1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 23 | DOCK7* | Dock7 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 24 | HCN1* | Hcn1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 25 | SLC13A5* | Slc13a5 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 26 | KCNB1* | Kcnb1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 27 | GRIN2B* | Grin2b | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 28 | WWOX* | Wwox | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 29 | AARS1* | Aars1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 3 | SLC25A22* | Slc25a22 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 30 | SIK1* | Sik1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 31A | DNM1* | Dnm1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 31B | DNM1* | Dnm1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 32 | KCNA2* | Kcna2 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 33 | EEF1A2* | Eef1a2 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 34 | SLC12A5* | Slc12a5 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 35 | ITPA* | Itpa | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 36 | ALG13* | Alg13 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 37 | FRRS1L* | Frrs1l | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 38 | ARV1* | Arv1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 4 | STXBP1* | Stxbp1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 40 | GUF1* | Guf1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 41 | SLC1A2* | Slc1a2 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 42 | CACNA1A* | Cacna1a | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 43 | GABRB3* | Gabrb3 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 44 | UBA5* | Uba5 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 45 | GABRB1* | Gabrb1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 46 | GRIN2D* | Grin2d | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 47 | FGF12* | Fgf12 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 48 | AP3B2* | Ap3b2 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 49 | DENND5A* | Dennd5a | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 5 | SPTAN1* | Sptan1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 50 | CAD* | Cad | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 51 | MDH2* | Mdh2 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 52 | SCN1B* | Scn1b | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 53 | SYNJ1* | Synj1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 55 | PIGP* | Pigp | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 56 | YWHAG* | Ywhag | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 57 | KCNT2* | Kcnt2 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 58 | NTRK2* | Ntrk2 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 59 | GABBR2* | Gabbr2 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 60 | CNPY3* | Cnpy3 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 61 | ADAM22* | Adam22 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 62 | SCN3A* | Scn3a | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 63 | CPLX1* | Cplx1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 64 | RHOBTB2* | Rhobtb2 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 65 | CYFIP2* | Cyfip2 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 66 | PACS2* | Pacs2 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 67 | CUX2* | Cux2 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 68 | TRAK1* | Trak1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 69 | CACNA1E* | Cacna1e | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 6B | SCN1A* | Scn1a | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 70 | PHACTR1* | Phactr1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 71 | GLS* | Gls | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 72 | NEUROD2* | Neurod2 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 73 | RNF13* | Rnf13 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 74 | GABRG2* | Gabrg2 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 75 | PARS2* | Pars2 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 76 | ACTL6B* | Actl6b | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 78 | GABRA2* | Gabra2 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 79 | GABRA5* | Gabra5 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 8 | ARHGEF9* | Arhgef9 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 80 | PIGB* | Pigb | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 81 | DMXL2* | Dmxl2 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 82 | GOT2* | Got2 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 83 | UGP2* | Ugp2 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 84 | UGDH* | Ugdh | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 85 | SMC1A* | Smc1a | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 86 | DALRD3* | Dalrd3 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 87 | CDK19* | Cdk19 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 88 | MDH1* | Mdh1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 89 | GAD1* | Gad1 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 9 | PCDH19* | Pcdh19 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 90 | FGF13* | Fgf13 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 91 | PPP3CA* | Ppp3ca | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 92 | GABRB2* | Gabrb2 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 93 | ATP6V1A* | Atp6v1a | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 94 | CHD2* | Chd2 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 95 | PIGS* | Pigs | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 96 | NSF* | Nsf | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 97 | CELF2* | Celf2 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 98 | ATP1A2* | Atp1a2 | Alliance of Genome Resources | ||||
| developmental and epileptic encephalopathy 99 | ATP1A3* | Atp1a3 | Alliance of Genome Resources | ||||
| dopa-responsive dystonia | GCH1* | Gch1 | Alliance of Genome Resources | ||||
| dysembryoplastic neuroepithelial tumor | BRAF* | Braf | Alliance of Genome Resources | ||||
| dystonia | SPR* | Spr | Alliance of Genome Resources | ||||
| dystonia | GCH1* | Gch1 | Alliance of Genome Resources | ||||
| dystonia | TIMM8A* | Timm8a1 | Alliance of Genome Resources | ||||
| dystonia 12 | ATP1A3* | Atp1a3 | Alliance of Genome Resources | ||||
| dystonia 12 | PLA2G6* | Pla2g6 | Alliance of Genome Resources | ||||
| dystonia 16 | PRKRA* | Prkra | Alliance of Genome Resources | ||||
| dystonia 22, adult-onset | TSPOAP1* | Tspoap1 | Alliance of Genome Resources | ||||
| dystonia 22, juvenile-onset | TSPOAP1* | Tspoap1 | Alliance of Genome Resources | ||||
| dystonia 24 | ANO3* | Ano3 | Alliance of Genome Resources | ||||
| dystonia 25 | GNAL* | Gnal | Alliance of Genome Resources | ||||
| dystonia 27 | COL6A3* | Col6a3 | Alliance of Genome Resources | ||||
| dystonia 28, childhood-onset | KMT2B* | Kmt2b | Alliance of Genome Resources | ||||
| dystonia 30 | VPS16* | Vps16 | Alliance of Genome Resources | ||||
| dystonia 31 | AOPEP* | Aopep | Alliance of Genome Resources | ||||
| dystonia 32 | VPS11* | Vps11 | Alliance of Genome Resources | ||||
| dystonia 33 | EIF2AK2* | Eif2ak2 | Alliance of Genome Resources | ||||
| dystonia 35, childhood-onset | SHQ1* | Shq1 | Alliance of Genome Resources | ||||
| dystonia 37, early-onset with striatal lesions | NUP54* | Nup54 | Alliance of Genome Resources | ||||
| dystonia 9 | SLC2A1* | Slc2a1 | Alliance of Genome Resources | ||||
| early-onset dystonia and/or spastic paraplegia | ATP5MC3* | Atp5mc3 | Alliance of Genome Resources | ||||
| early-onset epilepsy 2 | SETD1A* | Setd1a | Alliance of Genome Resources | ||||
| early-onset epilepsy 3 | ATP6V0C* | Atp6v0c | Alliance of Genome Resources | ||||
| early-onset vitamin B6-dependent epilepsy 1 | PLPBP* | Plpbp | Alliance of Genome Resources | ||||
| early-onset vitamin B6-dependent epilepsy 4 | ALDH7A1* | Aldh7a1 | Alliance of Genome Resources | ||||
| epilepsy | ABCB1* | Abcb1a, Abcb1b | Alliance of Genome Resources | ||||
| epilepsy | ACHE* | Ache | Alliance of Genome Resources | ||||
| epilepsy | ATP1A3* | Atp1a3 | Alliance of Genome Resources | ||||
| epilepsy | BCHE* | Bche | Alliance of Genome Resources | ||||
| epilepsy | CP* | Cp | Alliance of Genome Resources | ||||
| epilepsy | GDNF* | Gdnf | Alliance of Genome Resources | ||||
| epilepsy | GRIA1* | Gria1 | Alliance of Genome Resources | ||||
| epilepsy | KCNB1* | Kcnb1 | Alliance of Genome Resources | ||||
| epilepsy | POLG* | Polg | Alliance of Genome Resources | ||||
| epilepsy | TBX1* | Tbx1 | Alliance of Genome Resources | ||||
| episodic ataxia | CACNB4* | Cacnb4 | Alliance of Genome Resources | ||||
| episodic ataxia type 5 | CACNB4* | Cacnb4 | Alliance of Genome Resources | ||||
| episodic ataxia type 6 | SLC1A3* | Slc1a3 | Alliance of Genome Resources | ||||
| episodic ataxia type 9 | SCN2A* | Scn2a | Alliance of Genome Resources | ||||
| episodic kinesigenic dyskinesia 3 | TMEM151A* | Tmem151a | Alliance of Genome Resources | ||||
| essential tremor | DRD3* | Drd3 | Alliance of Genome Resources | ||||
| essential tremor | HNMT* | Hnmt | Alliance of Genome Resources | ||||
| essential tremor 1 | DRD3* | Drd3 | Alliance of Genome Resources | ||||
| essential tremor 4 | FUS* | Fus | Alliance of Genome Resources | ||||
| essential tremor 5 | TENM4* | Tenm4 | Alliance of Genome Resources | ||||
| essential tremor 6 | NOTCH2NLC* | ||||||
| extrapyramidal and movement disease | CYP2D6*, CYP2D7 | Cyp2d9, Cyp2d10, Cyp2d11, Cyp2d12, Cyp2d22, Cyp2d26, Cyp2d34, Cyp2d40 | Alliance of Genome Resources | ||||
| familial adult myoclonic epilepsy 1 | SAMD12* | Samd12 | Alliance of Genome Resources | ||||
| familial adult myoclonic epilepsy 2 | STARD7* | Stard7 | Alliance of Genome Resources | ||||
| familial adult myoclonic epilepsy 3 | MARCHF6* | Marchf6 | Alliance of Genome Resources | ||||
| familial adult myoclonic epilepsy 4 | YEATS2* | Yeats2 | Alliance of Genome Resources | ||||
| familial adult myoclonic epilepsy 5 | CNTN2* | Cntn2 | Alliance of Genome Resources | ||||
| familial adult myoclonic epilepsy 6 | TNRC6A* | Tnrc6a | Alliance of Genome Resources | ||||
| familial adult myoclonic epilepsy 7 | RAPGEF2* | Rapgef2 | Alliance of Genome Resources | ||||
| familial encephalopathy with neuroserpin inclusion bodies | SERPINB7* | Serpinb7 | Alliance of Genome Resources | ||||
| familial febrile seizures 11 | CPA6* | Cpa6 | Alliance of Genome Resources | ||||
| familial febrile seizures 2 | HCN2* | Hcn2 | Alliance of Genome Resources | ||||
| familial febrile seizures 4 | ADGRV1* | Adgrv1 | Alliance of Genome Resources | ||||
| familial febrile seizures 8 | GABRG2* | Gabrg2 | Alliance of Genome Resources | ||||
| familial focal epilepsy with variable foci 1 | DEPDC5* | Depdc5 | Alliance of Genome Resources | ||||
| familial focal epilepsy with variable foci 2 | NPRL2* | Nprl2 | Alliance of Genome Resources | ||||
| familial focal epilepsy with variable foci 3 | NPRL3* | Nprl3 | Alliance of Genome Resources | ||||
| familial focal epilepsy with variable foci 4 | SCN3A* | Scn3a | Alliance of Genome Resources | ||||
| familial hemiplegic migraine 1 | CACNA1A* | Cacna1a | Alliance of Genome Resources | ||||
| familial hemiplegic migraine 3 | SCN1A* | Scn1a | Alliance of Genome Resources | ||||
| familial meningioma | NF2* | Nf2 | 1 model | Alliance of Genome Resources | |||
| familial meningioma | SUFU* | Sufu | Alliance of Genome Resources | ||||
| familial meningioma | SMARCE1* | Smarce1 | Alliance of Genome Resources | ||||
| familial meningioma | PTEN* | Pten | Alliance of Genome Resources | ||||
| familial meningioma | PDGFB* | Pdgfb | Alliance of Genome Resources | ||||
| familial meningioma | MN1* | Mn1 | Alliance of Genome Resources | ||||
| familial temporal lobe epilepsy 5 | CPA6* | Cpa6 | Alliance of Genome Resources | ||||
| familial temporal lobe epilepsy 7 | RELN* | Reln | Alliance of Genome Resources | ||||
| familial temporal lobe epilepsy 8 | GAL* | Gal | Alliance of Genome Resources | ||||
| fatal familial insomnia | MIR146A* | Mir146 | Alliance of Genome Resources | ||||
| Fazio-Londe disease | SLC52A3* | Slc52a3 | Alliance of Genome Resources | ||||
| Friedreich ataxia | ND1* | mt-Nd1 | Alliance of Genome Resources | ||||
| Friedreich ataxia | AGTR1* | Agtr1a, Agtr1b | Alliance of Genome Resources | ||||
| Friedreich ataxia 1 | FXN* | Fxn | Alliance of Genome Resources | ||||
| frontotemporal dementia | GRN* | Grn | Alliance of Genome Resources | ||||
| frontotemporal dementia | MAPT* | Mapt | Alliance of Genome Resources | ||||
| frontotemporal dementia | MOBP* | Mobp | Alliance of Genome Resources | ||||
| frontotemporal dementia | PSEN1* | Psen1 | Alliance of Genome Resources | ||||
| frontotemporal dementia and/or amyotrophic lateral sclerosis 1 | C9orf72* | C9orf72 | Alliance of Genome Resources | ||||
| frontotemporal dementia and/or amyotrophic lateral sclerosis 2 | CHCHD10* | Chchd10 | Alliance of Genome Resources | ||||
| frontotemporal dementia and/or amyotrophic lateral sclerosis 3 | SQSTM1* | Sqstm1 | Alliance of Genome Resources | ||||
| frontotemporal dementia and/or amyotrophic lateral sclerosis 4 | TBK1* | Tbk1 | Alliance of Genome Resources | ||||
| frontotemporal dementia and/or amyotrophic lateral sclerosis 6 | VCP* | Vcp | Alliance of Genome Resources | ||||
| frontotemporal dementia and/or amyotrophic lateral sclerosis 7 | CHMP2B* | Chmp2b | Alliance of Genome Resources | ||||
| generalized epilepsy with febrile seizures plus | SLC32A1* | Slc32a1 | Alliance of Genome Resources | ||||
| generalized epilepsy with febrile seizures plus 1 | SCN1B* | Scn1b | Alliance of Genome Resources | ||||
| generalized epilepsy with febrile seizures plus 10 | HCN1* | Hcn1 | Alliance of Genome Resources | ||||
| generalized epilepsy with febrile seizures plus 2 | SCN1A* | Scn1a | Alliance of Genome Resources | ||||
| generalized epilepsy with febrile seizures plus 9 | STX1B* | Stx1b | Alliance of Genome Resources | ||||
| glioblastoma | DMBT1* | Dmbt1 | Alliance of Genome Resources | ||||
| glioblastoma | MMP9* | Mmp9 | Alliance of Genome Resources | ||||
| glioblastoma | NFKBIA* | Nfkbia | Alliance of Genome Resources | ||||
| glioblastoma | CDKN2A* | Cdkn2a | Alliance of Genome Resources | ||||
| glioblastoma | CDK4* | Cdk4 | Alliance of Genome Resources | ||||
| glioblastoma | ARRB2* | Arrb2 | Alliance of Genome Resources | ||||
| glioblastoma | AKT3* | Akt3 | Alliance of Genome Resources | ||||
| glioblastoma | ADGRB1* | Adgrb1 | Alliance of Genome Resources | ||||
| glioblastoma | PDGFB* | Pdgfb | Alliance of Genome Resources | ||||
| glioblastoma | PDGFRB* | Pdgfrb | Alliance of Genome Resources | ||||
| glioblastoma | PGF* | Pgf | Alliance of Genome Resources | ||||
| glioblastoma | PIK3CB* | Pik3cb | Alliance of Genome Resources | ||||
| glioblastoma | PTPRB* | Ptprb | Alliance of Genome Resources | ||||
| glioblastoma | RB1* | Rb1 | Alliance of Genome Resources | ||||
| glioblastoma | MAP1LC3A* | Map1lc3a | Alliance of Genome Resources | ||||
| glioblastoma | MGMT* | Mgmt | Alliance of Genome Resources | ||||
| glioblastoma | MDM2* | Mdm2 | Alliance of Genome Resources | ||||
| glioblastoma | LZTR1* | Lztr1 | Alliance of Genome Resources | ||||
| glioblastoma | KDR* | Kdr | Alliance of Genome Resources | ||||
| glioblastoma | IDH1* | Idh1 | Alliance of Genome Resources | ||||
| glioblastoma | FXN* | Fxn | Alliance of Genome Resources | ||||
| glioblastoma | FLT3LG* | Flt3l | Alliance of Genome Resources | ||||
| glioblastoma | EZH2* | Ezh2 | Alliance of Genome Resources | ||||
| glioblastoma | EGF* | Egf | Alliance of Genome Resources | ||||
| glioblastoma | NRAS* | Nras | Alliance of Genome Resources | ||||
| glioblastoma | RPL5* | Rpl5 | Alliance of Genome Resources | ||||
| glioblastoma | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
| glucose transporter type 1 deficiency syndrome 2 | SLC2A1* | Slc2a1 | Alliance of Genome Resources | ||||
| haemophilus meningitis | FCGR2A*, FCGR2B, FCGR2C | Fcgr2b, Fcgr3 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia | SPG21* | Spg21 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia | L2HGDH* | L2hgdh | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia | KIF1A* | Kif1a | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia | HSPD1* | Hspd1 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia | BSCL2* | Bscl2 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia | AP5Z1* | Ap5z1 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia | ALDH18A1* | Aldh18a1 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 10 | KIF5A* | Kif5a | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 12 | RTN2* | Rtn2 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 17 | BSCL2* | Bscl2 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 18 | ERLIN2* | Erlin2 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 23 | DSTYK* | Dstyk | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 26 | B4GALNT1* | B4galnt1 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 28 | DDHD1* | Ddhd1 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 39 | PNPLA6* | Pnpla6 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 3A | ATL1* | Atl1 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 42 | SLC33A1* | Slc33a1 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 43 | C19orf12* | 1600014C10Rik | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 44 | GJC2* | Gjc2 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 45 | NT5C2* | Nt5c2 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 46 | GBA2* | Gba2 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 47 | AP4B1* | Ap4b1 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 49 | TECPR2* | Tecpr2 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 50 | AP4M1* | Ap4m1 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 51 | AP4E1* | Ap4e1 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 52 | AP4S1* | Ap4s1 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 53 | VPS37A* | Vps37a | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 55 | MTRFR* | Mtrfr | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 56 | CYP2U1* | Cyp2u1 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 57 | TFG* | Tfg | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 5A | CYP7B1* | Cyp7b1 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 6 | NIPA1* | Nipa1 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 61 | ARL6IP1* | Arl6ip1 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 62 | ERLIN1* | Erlin1 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 63 | AMPD2* | Ampd2 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 64 | ENTPD1* | Entpd1 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 70 | MARS1* | Mars1 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 72A | REEP2* | Reep2 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 73 | CPT1C* | Cpt1c | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 74 | IBA57* | Iba57 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 75 | MAG* | Mag | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 76 | CAPN1* | Capn1 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 77 | FARS2* | Fars2 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 78 | ATP13A2* | Atp13a2 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 79A | UCHL1* | Uchl1 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 79B | UCHL1* | Uchl1 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 8 | WASHC5* | Washc5 | 1 "NOT" model | Alliance of Genome Resources | |||
| hereditary spastic paraplegia 81 | SELENOI* | Selenoi | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 82 | PCYT2* | Pcyt2 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 83 | HPDL* | Hpdl | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 84 | PI4KA* | Pi4ka | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 85 | RNF170* | Rnf170 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 86 | ABHD16A* | Abhd16a | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 87 | TMEM63C* | Tmem63c | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 88 | KPNA3* | Kpna3 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 89 | AMFR* | Amfr | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 90A | SPTSSA* | Sptssa | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 90B | SPTSSA* | Sptssa | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 9A | ALDH18A1* | Aldh18a1 | Alliance of Genome Resources | ||||
| hereditary spastic paraplegia 9B | ALDH18A1* | Aldh18a1 | Alliance of Genome Resources | ||||
| Huntington's disease | BDNF* | Bdnf | Alliance of Genome Resources | ||||
| Huntington's disease | ABAT* | Abat | Alliance of Genome Resources | ||||
| Huntington's disease | EIF2AK2* | Eif2ak2 | Alliance of Genome Resources | ||||
| Huntington's disease | GLUL* | Glul | Alliance of Genome Resources | ||||
| Huntington's disease | GRIK2* | Grik2 | Alliance of Genome Resources | ||||
| Huntington's disease | GRIN2A* | Grin2a | Alliance of Genome Resources | ||||
| Huntington's disease | GRIN2B* | Grin2b | Alliance of Genome Resources | ||||
| Huntington's disease | HAP1* | Hap1 | 2 "NOT" models | Alliance of Genome Resources | |||
| Huntington's disease | HSF1* | Hsf1 | Alliance of Genome Resources | ||||
| Huntington's disease | IGF1* | Igf1 | Alliance of Genome Resources | ||||
| Huntington's disease | IL6* | Il6 | Alliance of Genome Resources | ||||
| Huntington's disease | IL6R* | Il6ra | Alliance of Genome Resources | ||||
| Huntington's disease | MAP3K5* | Map3k5 | Alliance of Genome Resources | ||||
| Huntington's disease | NOG* | Nog | Alliance of Genome Resources | ||||
| Huntington's disease | NPY* | Npy | Alliance of Genome Resources | ||||
| Huntington's disease | NPY2R* | Npy2r | Alliance of Genome Resources | ||||
| Huntington's disease | NRF1* | Nrf1 | Alliance of Genome Resources | ||||
| Huntington's disease | PPARGC1A* | Ppargc1a | Alliance of Genome Resources | ||||
| Huntington's disease | PRKAA1* | Prkaa1 | Alliance of Genome Resources | ||||
| Huntington's disease | SIRT1* | Sirt1 | Alliance of Genome Resources | ||||
| Huntington's disease | TFAM* | Tfam | Alliance of Genome Resources | ||||
| Huntington's disease | CNTF* | Cntf | Alliance of Genome Resources | ||||
| Huntington's disease-like 1 | PRNP* | Prnp | Alliance of Genome Resources | ||||
| Huntington's disease-like 2 | JPH3* | Jph3 | Alliance of Genome Resources | ||||
| hydrocephalus | WDR81* | Wdr81 | Alliance of Genome Resources | ||||
| hydrocephalus | MPDZ* | Mpdz | Alliance of Genome Resources | ||||
| hydrocephalus | L1CAM* | L1cam | Alliance of Genome Resources | ||||
| hydrocephalus | CCDC88C* | Ccdc88c | Alliance of Genome Resources | ||||
| hydrocephalus | SMARCC1* | Smarcc1 | Alliance of Genome Resources | ||||
| hypomyelinating leukodystrophy | POLR1A* | Polr1a | Alliance of Genome Resources | ||||
| hypomyelinating leukodystrophy 10 | PYCR2* | Pycr2 | Alliance of Genome Resources | ||||
| hypomyelinating leukodystrophy 11 | POLR1C* | Polr1c | Alliance of Genome Resources | ||||
| hypomyelinating leukodystrophy 12 | VPS11* | Vps11 | Alliance of Genome Resources | ||||
| hypomyelinating leukodystrophy 13 | HIKESHI* | Hikeshi | Alliance of Genome Resources | ||||
| hypomyelinating leukodystrophy 14 | UFM1* | Ufm1 | Alliance of Genome Resources | ||||
| hypomyelinating leukodystrophy 15 | EPRS1* | Eprs1 | Alliance of Genome Resources | ||||
| hypomyelinating leukodystrophy 16 | TMEM106B* | Tmem106b | Alliance of Genome Resources | ||||
| hypomyelinating leukodystrophy 17 | AIMP2* | Aimp2 | Alliance of Genome Resources | ||||
| hypomyelinating leukodystrophy 18 | DEGS1* | Degs1, Degs1l | Alliance of Genome Resources | ||||
| hypomyelinating leukodystrophy 19 | TMEM63A* | Tmem63a | Alliance of Genome Resources | ||||
| hypomyelinating leukodystrophy 20 | CNP* | Cnp | Alliance of Genome Resources | ||||
| hypomyelinating leukodystrophy 21 | POLR3K* | Polr3k | Alliance of Genome Resources | ||||
| hypomyelinating leukodystrophy 22 | CLDN11* | Cldn11 | Alliance of Genome Resources | ||||
| hypomyelinating leukodystrophy 23 | RNF220* | Rnf220 | Alliance of Genome Resources | ||||
| hypomyelinating leukodystrophy 24 | ATP11A* | Atp11a | Alliance of Genome Resources | ||||
| hypomyelinating leukodystrophy 25 | TMEM163* | Tmem163 | Alliance of Genome Resources | ||||
| hypomyelinating leukodystrophy 26 | SLC35B2* | Slc35b2 | Alliance of Genome Resources | ||||
| hypomyelinating leukodystrophy 3 | AIMP1* | Aimp1 | Alliance of Genome Resources | ||||
| hypomyelinating leukodystrophy 4 | HSPD1* | Hspd1 | Alliance of Genome Resources | ||||
| hypomyelinating leukodystrophy 5 | HYCC1* | Hycc1 | Alliance of Genome Resources | ||||
| hypomyelinating leukodystrophy 7 | POLR3A* | Polr3a | 2 "NOT" models | Alliance of Genome Resources | |||
| hypomyelinating leukodystrophy 8 | POLR3B* | Polr3b | Alliance of Genome Resources | ||||
| hypomyelinating leukodystrophy 9 | RARS1* | Rars1 | Alliance of Genome Resources | ||||
| idiopathic generalized epilepsy | KCNMA1* | Kcnma1 | Alliance of Genome Resources | ||||
| idiopathic generalized epilepsy | HCN4* | Hcn4 | Alliance of Genome Resources | ||||
| idiopathic generalized epilepsy 10 | GABRD* | Gabrd | Alliance of Genome Resources | ||||
| idiopathic generalized epilepsy 11 | CLCN2* | Clcn2 | Alliance of Genome Resources | ||||
| idiopathic generalized epilepsy 12 | SLC2A1* | Slc2a1 | Alliance of Genome Resources | ||||
| idiopathic generalized epilepsy 13 | GABRA1* | Gabra1 | Alliance of Genome Resources | ||||
| idiopathic generalized epilepsy 14 | SLC12A5* | Slc12a5 | Alliance of Genome Resources | ||||
| idiopathic generalized epilepsy 15 | RORB* | Rorb | Alliance of Genome Resources | ||||
| idiopathic generalized epilepsy 8 | CASR* | Casr | Alliance of Genome Resources | ||||
| idiopathic generalized epilepsy 9 | CACNB4* | Cacnb4 | Alliance of Genome Resources | ||||
| infantile cerebellar-retinal degeneration | ACO2* | Aco2 | Alliance of Genome Resources | ||||
| infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly | MED17* | Med17 | Alliance of Genome Resources | ||||
| infantile parkinsonism-dystonia 2 | SLC18A2* | Slc18a2 | Alliance of Genome Resources | ||||
| intermediate spinal muscular atrophy | SMN1*, SMN2 | Smn1 | 1 model | Alliance of Genome Resources | |||
| intracranial aneurysm | COL1A2* | Col1a2 | Alliance of Genome Resources | ||||
| intracranial aneurysm | BCL2* | Bcl2 | Alliance of Genome Resources | ||||
| intracranial aneurysm | COL22A1* | Col22a1 | Alliance of Genome Resources | ||||
| intracranial aneurysm | ENG* | Eng | Alliance of Genome Resources | ||||
| intracranial aneurysm | IL6* | Il6 | Alliance of Genome Resources | ||||
| intracranial aneurysm | KMT2D* | Kmt2d | Alliance of Genome Resources | ||||
| intracranial aneurysm | MMP2* | Mmp2 | Alliance of Genome Resources | ||||
| intracranial aneurysm | MMP9* | Mmp9 | Alliance of Genome Resources | ||||
| intracranial aneurysm | PKD1* | Pkd1 | Alliance of Genome Resources | ||||
| intracranial aneurysm | PKD2* | Pkd2 | Alliance of Genome Resources | ||||
| intracranial aneurysm | SOX17* | Sox17 | Alliance of Genome Resources | ||||
| intracranial aneurysm | VCAN* | Vcan | Alliance of Genome Resources | ||||
| intracranial berry aneurysm 12 | THSD1* | Thsd1 | Alliance of Genome Resources | ||||
| intracranial embolism | KL* | Kl | Alliance of Genome Resources | ||||
| intracranial vasospasm | HMOX1* | Hmox1 | Alliance of Genome Resources | ||||
| intracranial vasospasm | RYR1* | Ryr1 | Alliance of Genome Resources | ||||
| Joubert syndrome | TOGARAM1* | Togaram1 | Alliance of Genome Resources | ||||
| Joubert syndrome | INPP5E* | Inpp5e | Alliance of Genome Resources | ||||
| Joubert syndrome | IFT74* | Ift74 | Alliance of Genome Resources | ||||
| Joubert syndrome | FAM149B1* | Fam149b | Alliance of Genome Resources | ||||
| Joubert syndrome | B9D2* | B9d2 | Alliance of Genome Resources | ||||
| Joubert syndrome | KIAA0753* | 4933427D14Rik | Alliance of Genome Resources | ||||
| Joubert syndrome | TMEM218* | Tmem218 | Alliance of Genome Resources | ||||
| Joubert syndrome | TMEM237* | Tmem237 | Alliance of Genome Resources | ||||
| Joubert syndrome | TMEM216* | Tmem216 | Alliance of Genome Resources | ||||
| Joubert syndrome | ARL3* | Arl3 | Alliance of Genome Resources | ||||
| Joubert syndrome 1 | INPP5E* | Inpp5e | Alliance of Genome Resources | ||||
| Joubert syndrome 10 | OFD1* | Ofd1 | Alliance of Genome Resources | ||||
| Joubert syndrome 13 | TCTN1* | Tctn1 | Alliance of Genome Resources | ||||
| Joubert syndrome 14 | TMEM237* | Tmem237 | Alliance of Genome Resources | ||||
| Joubert syndrome 15 | CEP41* | Cep41 | Alliance of Genome Resources | ||||
| Joubert syndrome 16 | TMEM138* | Tmem138 | Alliance of Genome Resources | ||||
| Joubert syndrome 18 | TCTN3* | Tctn3 | Alliance of Genome Resources | ||||
| Joubert syndrome 2 | TMEM216* | Tmem216 | Alliance of Genome Resources | ||||
| Joubert syndrome 20 | TMEM231* | Tmem231 | Alliance of Genome Resources | ||||
| Joubert syndrome 21 | CSPP1* | Cspp1 | Alliance of Genome Resources | ||||
| Joubert syndrome 22 | PDE6D* | Pde6d | Alliance of Genome Resources | ||||
| Joubert syndrome 23 | KIAA0586* | 2700049A03Rik | Alliance of Genome Resources | ||||
| Joubert syndrome 24 | TCTN2* | Tctn2 | Alliance of Genome Resources | ||||
| Joubert syndrome 25 | CEP104* | Cep104 | Alliance of Genome Resources | ||||
| Joubert syndrome 27 | B9D1* | B9d1 | Alliance of Genome Resources | ||||
| Joubert syndrome 28 | MKS1* | Mks1 | Alliance of Genome Resources | ||||
| Joubert syndrome 30 | ARMC9* | Armc9 | Alliance of Genome Resources | ||||
| Joubert syndrome 31 | CEP120* | Cep120 | Alliance of Genome Resources | ||||
| Joubert syndrome 32 | SUFU* | Sufu | Alliance of Genome Resources | ||||
| Joubert syndrome 33 | PIBF1* | Pibf1 | Alliance of Genome Resources | ||||
| Joubert syndrome 4 | AHI1* | Ahi1 | Alliance of Genome Resources | ||||
| Joubert syndrome 4 | NPHP4* | Nphp4 | Alliance of Genome Resources | ||||
| Joubert syndrome 4 | NPHP1* | Nphp1 | Alliance of Genome Resources | ||||
| Joubert syndrome 8 | ARL13B* | Arl13b | Alliance of Genome Resources | ||||
| Joubert syndrome 9 | CC2D2A* | Cc2d2a | Alliance of Genome Resources | ||||
| Joubert syndrome with orofaciodigital defect | CPLANE1* | Cplane1 | Alliance of Genome Resources | ||||
| juvenile absence epilepsy 1 | EFHC1* | Efhc1 | Alliance of Genome Resources | ||||
| juvenile amyotrophic lateral sclerosis type 27 | SPTLC1* | Sptlc1 | Alliance of Genome Resources | ||||
| juvenile myoclonic epilepsy | BRD2* | Brd2 | Alliance of Genome Resources | ||||
| juvenile myoclonic epilepsy 10 | CILK1* | Cilk1 | Alliance of Genome Resources | ||||
| Kennedy's disease | AR* | Ar | 1 model | Alliance of Genome Resources | |||
| kuru | PRNP* | Prnp | Alliance of Genome Resources | ||||
| late onset Parkinson's disease | ATXN3* | Atxn3 | Alliance of Genome Resources | ||||
| late onset Parkinson's disease | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
| late onset Parkinson's disease | HLA-DRA* | H2-Ea | Alliance of Genome Resources | ||||
| late onset Parkinson's disease | TBP* | Tbp | Alliance of Genome Resources | ||||
| late onset Parkinson's disease | PSAP* | Psap | Alliance of Genome Resources | ||||
| late onset Parkinson's disease | MAPT* | Mapt | Alliance of Genome Resources | ||||
| late onset Parkinson's disease | ADH1C*, ADH1A, ADH1B | Adh1 | Alliance of Genome Resources | ||||
| late onset Parkinson's disease | GBA1* | Gba1 | Alliance of Genome Resources | ||||
| late onset Parkinson's disease | ATXN2* | Atxn2 | Alliance of Genome Resources | ||||
| late onset Parkinson's disease | EIF4G1* | Eif4g1 | Alliance of Genome Resources | ||||
| late onset Parkinson's disease | ATXN8OS* | ||||||
| leukodystrophy | AARS1* | Aars1 | Alliance of Genome Resources | ||||
| leukoencephalopathy with vanishing white matter | EIF2B2* | Eif2b2 | Alliance of Genome Resources | ||||
| leukoencephalopathy with vanishing white matter 1 | EIF2B1* | Eif2b1 | Alliance of Genome Resources | ||||
| leukoencephalopathy with vanishing white matter 2 | EIF2B2* | Eif2b2 | Alliance of Genome Resources | ||||
| leukoencephalopathy with vanishing white matter 3 | EIF2B3* | Eif2b3 | Alliance of Genome Resources | ||||
| leukoencephalopathy with vanishing white matter 4 | EIF2B4* | Eif2b4 | Alliance of Genome Resources | ||||
| leukoencephalopathy with vanishing white matter 5 | EIF2B5* | Eif2b5 | Alliance of Genome Resources | ||||
| Machado-Joseph disease | BECN1* | Becn1 | Alliance of Genome Resources | ||||
| Machado-Joseph disease | ATXN3* | Atxn3 | 1 model | Alliance of Genome Resources | |||
| malignant astrocytoma | KRAS* | Kras | Alliance of Genome Resources | ||||
| malignant astrocytoma | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
| malignant astrocytoma | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| malignant astrocytoma | CADM2* | Cadm2 | Alliance of Genome Resources | ||||
| malignant astrocytoma | BRAF* | Braf | Alliance of Genome Resources | ||||
| McLeod syndrome | XK* | Xk | Alliance of Genome Resources | ||||
| medulloblastoma | APC* | Apc | Alliance of Genome Resources | ||||
| medulloblastoma | BRCA2* | Brca2 | 2 models | Alliance of Genome Resources | |||
| medulloblastoma | CTNNB1* | Ctnnb1 | Alliance of Genome Resources | ||||
| medulloblastoma | ELP1* | Elp1 | Alliance of Genome Resources | ||||
| medulloblastoma | GPR161* | Gpr161 | Alliance of Genome Resources | ||||
| medulloblastoma | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| medulloblastoma | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| medulloblastoma | PTCH2* | Ptch2 | 2 models | Alliance of Genome Resources | |||
| medulloblastoma | SUFU* | Sufu | 1 model | Alliance of Genome Resources | |||
| medulloblastoma | TSC2* | Tsc2 | Alliance of Genome Resources | ||||
| megalencephalic leukoencephalopathy with subcortical cysts | GPRC5B* | Gprc5b | Alliance of Genome Resources | ||||
| megalencephalic leukoencephalopathy with subcortical cysts | AQP4* | Aqp4 | Alliance of Genome Resources | ||||
| megalencephalic leukoencephalopathy with subcortical cysts 2A | HEPACAM* | Hepacam | Alliance of Genome Resources | ||||
| megalencephalic leukoencephalopathy with subcortical cysts 2B | HEPACAM* | Hepacam | Alliance of Genome Resources | ||||
| meningioma | MN1* | Mn1 | Alliance of Genome Resources | ||||
| meningioma | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
| meningioma | SMARCB1* | Smarcb1 | Alliance of Genome Resources | ||||
| meningioma | SMARCE1* | Smarce1 | Alliance of Genome Resources | ||||
| meningioma | NF2* | Nf2 | Alliance of Genome Resources | ||||
| meningioma | MTRR* | Mtrr | Alliance of Genome Resources | ||||
| meningioma | XRCC3* | Xrcc3 | Alliance of Genome Resources | ||||
| meningioma | GSTM3* | Gstm5 | Alliance of Genome Resources | ||||
| meningococcal meningitis | CD46* | Cd46 | Alliance of Genome Resources | ||||
| meningococcal meningitis | TLR2* | Tlr2 | Alliance of Genome Resources | ||||
| meningococcal meningitis | TLR4* | Tlr4 | Alliance of Genome Resources | ||||
| meningococcal meningitis | NOD2* | Nod2 | Alliance of Genome Resources | ||||
| microcephaly, seizures, and developmental delay | PNKP* | Pnkp | Alliance of Genome Resources | ||||
| middle cerebral artery infarction | ALB* | Alb | Alliance of Genome Resources | ||||
| middle cerebral artery infarction | SHH* | Shh | Alliance of Genome Resources | ||||
| middle cerebral artery infarction | CSF3* | Csf3 | Alliance of Genome Resources | ||||
| middle cerebral artery infarction | CRP* | Crp | Alliance of Genome Resources | ||||
| middle cerebral artery infarction | F12* | F12 | Alliance of Genome Resources | ||||
| middle cerebral artery infarction | HMOX1* | Hmox1 | Alliance of Genome Resources | ||||
| middle cerebral artery infarction | EPO* | Epo | Alliance of Genome Resources | ||||
| middle cerebral artery infarction | CXCL10* | Cxcl10 | Alliance of Genome Resources | ||||
| middle cerebral artery infarction | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
| middle cerebral artery infarction | NCAM1* | Ncam1 | Alliance of Genome Resources | ||||
| middle cerebral artery infarction | NRG1* | Nrg1 | Alliance of Genome Resources | ||||
| middle cerebral artery infarction | PARK7* | Park7 | Alliance of Genome Resources | ||||
| migraine | ESR1* | Esr1 | Alliance of Genome Resources | ||||
| migraine | EDNRA* | Ednra | Alliance of Genome Resources | ||||
| migraine | PHACTR1* | Phactr1 | Alliance of Genome Resources | ||||
| migraine | CALCA*, CALCB | Calca, Calcb | Alliance of Genome Resources | ||||
| migraine | TNF* | Tnf | Alliance of Genome Resources | ||||
| migraine | CACNA1A* | Cacna1a | Alliance of Genome Resources | ||||
| migraine | TRPV1* | Trpv1 | Alliance of Genome Resources | ||||
| migraine | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| migraine | KCNK18* | Kcnk18 | Alliance of Genome Resources | ||||
| migraine | NOS3* | Nos3 | Alliance of Genome Resources | ||||
| migraine with aura | TRPV3* | Trpv3 | Alliance of Genome Resources | ||||
| migraine with aura | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| migraine with aura | DRD2* | Drd2 | Alliance of Genome Resources | ||||
| migraine with aura | DBH* | Dbh | Alliance of Genome Resources | ||||
| migraine with aura | CACNA1A* | Cacna1a | Alliance of Genome Resources | ||||
| migraine with aura | ATP1A2* | Atp1a2 | Alliance of Genome Resources | ||||
| migraine without aura | LDLR* | Ldlr | Alliance of Genome Resources | ||||
| migraine without aura | TNF* | Tnf | Alliance of Genome Resources | ||||
| motor neuron disease | SOD1* | Sod1 | Alliance of Genome Resources | ||||
| motor neuron disease | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| motor neuron disease | TARDBP* | Tardbp | Alliance of Genome Resources | ||||
| motor neuron disease | HTRA2* | Htra2 | Alliance of Genome Resources | ||||
| movement disease | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| movement disease | DRD2* | Drd2 | Alliance of Genome Resources | ||||
| movement disease | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
| Moyamoya disease | ANO1* | Ano1 | Alliance of Genome Resources | ||||
| Moyamoya disease | HLA-A*, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
| Moyamoya disease | ACTA2* | Acta2 | Alliance of Genome Resources | ||||
| Moyamoya disease | TIMP2* | Timp2 | Alliance of Genome Resources | ||||
| Moyamoya disease | PHACTR1* | Phactr1 | Alliance of Genome Resources | ||||
| Moyamoya disease | RNF213* | Rnf213 | 1 "NOT" model | Alliance of Genome Resources | |||
| Moyamoya disease | GUCY1A1* | Gucy1a1 | Alliance of Genome Resources | ||||
| multiple sclerosis | HLA-DPB1* | ||||||
| multiple sclerosis | A2M* | A2m | Alliance of Genome Resources | ||||
| multiple sclerosis | AGER* | Ager | Alliance of Genome Resources | ||||
| multiple sclerosis | APOC2* | Apoc2, Apoc2l | Alliance of Genome Resources | ||||
| multiple sclerosis | ATP6* | Atp6-ps, mt-Atp6 | Alliance of Genome Resources | ||||
| multiple sclerosis | CAV1* | Cav1 | Alliance of Genome Resources | ||||
| multiple sclerosis | CCL1* | Ccl1 | Alliance of Genome Resources | ||||
| multiple sclerosis | CCL2*, CCL13* | Ccl2, Ccl12 | Alliance of Genome Resources | ||||
| multiple sclerosis | CCL7* | Ccl7 | Alliance of Genome Resources | ||||
| multiple sclerosis | CCR5* | Ccr5 | Alliance of Genome Resources | ||||
| multiple sclerosis | CD24* | Cd24a | Alliance of Genome Resources | ||||
| multiple sclerosis | CD28* | Cd28 | Alliance of Genome Resources | ||||
| multiple sclerosis | CD40* | Cd40 | Alliance of Genome Resources | ||||
| multiple sclerosis | CD46* | Cd46 | Alliance of Genome Resources | ||||
| multiple sclerosis | CD86* | Cd86 | Alliance of Genome Resources | ||||
| multiple sclerosis | CIITA* | Ciita | Alliance of Genome Resources | ||||
| multiple sclerosis | CLEC16A* | Clec16a | Alliance of Genome Resources | ||||
| multiple sclerosis | CNP* | Cnp | Alliance of Genome Resources | ||||
| multiple sclerosis | CNTF* | Cntf | Alliance of Genome Resources | ||||
| multiple sclerosis | CTLA4* | Ctla4 | Alliance of Genome Resources | ||||
| multiple sclerosis | FAS* | Fas | Alliance of Genome Resources | ||||
| multiple sclerosis | FASLG* | Fasl | Alliance of Genome Resources | ||||
| multiple sclerosis | GABRA3* | Gabra3 | Alliance of Genome Resources | ||||
| multiple sclerosis | GC* | Gc | Alliance of Genome Resources | ||||
| multiple sclerosis | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| multiple sclerosis | GSTM3* | Gstm5 | Alliance of Genome Resources | ||||
| multiple sclerosis | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
| multiple sclerosis | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| multiple sclerosis | HLA-DQA1*, HLA-DQA2 | H2-Aa | 1 model | Alliance of Genome Resources | |||
| multiple sclerosis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | 1 model | Alliance of Genome Resources | |||
| multiple sclerosis | HLA-DRA* | H2-Ea | 1 model | Alliance of Genome Resources | |||
| multiple sclerosis | HLA-DRB1*, HLA-DRB3*, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | 1 model | Alliance of Genome Resources | |||
| multiple sclerosis | H6PD* | H6pd | Alliance of Genome Resources | ||||
| multiple sclerosis | HSP90AB1*, HSP90AB2P, HSP90AB3P, HSP90AB4P | Hsp90ab1 | Alliance of Genome Resources | ||||
| multiple sclerosis | IFNB1* | Ifnb1 | Alliance of Genome Resources | ||||
| multiple sclerosis | IFNG* | Ifng | Alliance of Genome Resources | ||||
| multiple sclerosis | IL1B* | Il1b | Alliance of Genome Resources | ||||
| multiple sclerosis | IL2RA* | Il2ra | Alliance of Genome Resources | ||||
| multiple sclerosis | IL4* | Il4 | Alliance of Genome Resources | ||||
| multiple sclerosis | IL4R* | Il4ra | Alliance of Genome Resources | ||||
| multiple sclerosis | IL6* | Il6 | Alliance of Genome Resources | ||||
| multiple sclerosis | IL21R* | Il21r | Alliance of Genome Resources | ||||
| multiple sclerosis | IL23R* | Il23r | Alliance of Genome Resources | ||||
| multiple sclerosis | IRF5* | Irf5 | Alliance of Genome Resources | ||||
| multiple sclerosis | JAG1* | Jag1 | Alliance of Genome Resources | ||||
| multiple sclerosis | KIF1B* | Kif1b | Alliance of Genome Resources | ||||
| multiple sclerosis | KIF5A* | Kif5a | Alliance of Genome Resources | ||||
| multiple sclerosis | MBP* | Mbp | Alliance of Genome Resources | ||||
| multiple sclerosis | MMP9* | Mmp9 | Alliance of Genome Resources | ||||
| multiple sclerosis | MMP12* | Mmp12 | Alliance of Genome Resources | ||||
| multiple sclerosis | MOG* | Mog | 4 models | Alliance of Genome Resources | |||
| multiple sclerosis | MPHOSPH9* | Mphosph9 | Alliance of Genome Resources | ||||
| multiple sclerosis | ATP8* | mt-Atp8 | Alliance of Genome Resources | ||||
| multiple sclerosis | ND2* | mt-Nd2 | Alliance of Genome Resources | ||||
| multiple sclerosis | NDUFS2* | Ndufs2 | Alliance of Genome Resources | ||||
| multiple sclerosis | NECTIN2* | Nectin2 | Alliance of Genome Resources | ||||
| multiple sclerosis | NOTCH4* | Notch4 | Alliance of Genome Resources | ||||
| multiple sclerosis | PDCD1* | Pdcd1 | Alliance of Genome Resources | ||||
| multiple sclerosis | PHACTR2* | Phactr2 | Alliance of Genome Resources | ||||
| multiple sclerosis | PNMT* | Pnmt | Alliance of Genome Resources | ||||
| multiple sclerosis | POLG* | Polg | Alliance of Genome Resources | ||||
| multiple sclerosis | PSMB9* | Psmb9 | Alliance of Genome Resources | ||||
| multiple sclerosis | PTPRC* | Ptprc | Alliance of Genome Resources | ||||
| multiple sclerosis | RGMA* | Rgma | Alliance of Genome Resources | ||||
| multiple sclerosis | SH2D2A* | Sh2d2a | Alliance of Genome Resources | ||||
| multiple sclerosis | SLC11A1* | Slc11a1 | Alliance of Genome Resources | ||||
| multiple sclerosis | SPP1* | Spp1 | Alliance of Genome Resources | ||||
| multiple sclerosis | TAP2* | Tap2 | Alliance of Genome Resources | ||||
| multiple sclerosis | TNFRSF1A* | Tnfrsf1a | 1 model | Alliance of Genome Resources | |||
| multiple sclerosis | VDR* | Vdr | Alliance of Genome Resources | ||||
| multiple system atrophy | KLK6* | Klk6 | Alliance of Genome Resources | ||||
| myelitis | HLA-DPB1* | ||||||
| myelomeningocele | SLC2A1* | Slc2a1 | Alliance of Genome Resources | ||||
| myoclonic-atonic epilepsy | SLC6A1* | Slc6a1 | Alliance of Genome Resources | ||||
| myoclonic-atonic epilepsy | TBC1D24* | Tbc1d24 | Alliance of Genome Resources | ||||
| myoclonic dystonia 26 | KCTD17* | Kctd17 | Alliance of Genome Resources | ||||
| myoclonic dystonia 34 | KCNN2* | Kcnn2 | Alliance of Genome Resources | ||||
| neuroaxonal dystrophy | NAGA* | Naga | Alliance of Genome Resources | ||||
| neuroaxonal dystrophy | PLA2G6* | Pla2g6 | Alliance of Genome Resources | ||||
| neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset | SQSTM1* | Sqstm1 | Alliance of Genome Resources | ||||
| neurodegeneration with brain iron accumulation | CRAT* | Crat | Alliance of Genome Resources | ||||
| neurodegeneration with brain iron accumulation | FTH1* | Fth1 | Alliance of Genome Resources | ||||
| neurodegeneration with brain iron accumulation | REPS1* | Reps1 | Alliance of Genome Resources | ||||
| neurodegeneration with brain iron accumulation 2b | PLA2G6* | Pla2g6 | Alliance of Genome Resources | ||||
| neurodegeneration with brain iron accumulation 3 | FTL* | Ftl1, Ftl1-ps2, Ftl2-ps | Alliance of Genome Resources | ||||
| neurodegeneration with brain iron accumulation 4 | C19orf12* | 1600014C10Rik | Alliance of Genome Resources | ||||
| neurodegenerative disease | FTL* | Ftl1, Ftl1-ps2, Ftl2-ps | Alliance of Genome Resources | ||||
| neurodegenerative disease | EPO* | Epo | Alliance of Genome Resources | ||||
| neurodegenerative disease | FUS* | Fus | Alliance of Genome Resources | ||||
| neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures | IRF2BPL* | Irf2bpl | Alliance of Genome Resources | ||||
| neuromyelitis optica | AQP4* | Aqp4 | Alliance of Genome Resources | ||||
| neuromyelitis optica | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| neuromyelitis optica | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| neuronal intranuclear inclusion disease | NOTCH2NLC* | ||||||
| nonprogressive cerebellar ataxia with mental retardation | CAMTA1* | Camta1 | Alliance of Genome Resources | ||||
| olivopontocerebellar atrophy | APTX* | Aptx | Alliance of Genome Resources | ||||
| optic nerve glioma | NF1* | Nf1 | Alliance of Genome Resources | ||||
| pantothenate kinase-associated neurodegeneration | PANK2* | Pank2 | 1 "NOT" model | Alliance of Genome Resources | |||
| Parkinsonism | LRRK2* | Lrrk2 | Alliance of Genome Resources | ||||
| Parkinsonism | FGF2* | Fgf2 | Alliance of Genome Resources | ||||
| Parkinsonism | HSPA1A*, HSPA1B | Hspa1a, Hspa1b | Alliance of Genome Resources | ||||
| Parkinsonism | TNFRSF1B* | Tnfrsf1b | Alliance of Genome Resources | ||||
| Parkinsonism | GDNF* | Gdnf | Alliance of Genome Resources | ||||
| Parkinsonism | MANF* | Manf | Alliance of Genome Resources | ||||
| Parkinsonism | BDNF* | Bdnf | Alliance of Genome Resources | ||||
| Parkinsonism | GCH1* | Gch1 | Alliance of Genome Resources | ||||
| Parkinsonism | PARK7* | Park7 | Alliance of Genome Resources | ||||
| Parkinsonism | GBA1* | Gba1 | Alliance of Genome Resources | ||||
| Parkinsonism | TH* | Th | Alliance of Genome Resources | ||||
| Parkinson's disease | IL1B* | Il1b | Alliance of Genome Resources | ||||
| Parkinson's disease | EIF2AK2* | Eif2ak2 | Alliance of Genome Resources | ||||
| Parkinson's disease | EPHX1* | Ephx1 | Alliance of Genome Resources | ||||
| Parkinson's disease | EPO* | Epo | Alliance of Genome Resources | ||||
| Parkinson's disease | ESR2* | Esr2 | Alliance of Genome Resources | ||||
| Parkinson's disease | FBXO7* | Fbxo7 | Alliance of Genome Resources | ||||
| Parkinson's disease | GBA1* | Gba1 | Alliance of Genome Resources | ||||
| Parkinson's disease | GDF5* | Gdf5 | Alliance of Genome Resources | ||||
| Parkinson's disease | GIGYF2* | Gigyf2 | Alliance of Genome Resources | ||||
| Parkinson's disease | GRK6* | Grk6 | Alliance of Genome Resources | ||||
| Parkinson's disease | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| Parkinson's disease | GSTO1* | Gsto1 | Alliance of Genome Resources | ||||
| Parkinson's disease | GSTO2* | Gsto2 | Alliance of Genome Resources | ||||
| Parkinson's disease | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
| Parkinson's disease | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| Parkinson's disease | HLA-DRA* | H2-Ea | Alliance of Genome Resources | ||||
| Parkinson's disease | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| Parkinson's disease | HMGCR* | Hmgcr | Alliance of Genome Resources | ||||
| Parkinson's disease | HNMT* | Hnmt | Alliance of Genome Resources | ||||
| Parkinson's disease | HSPA8* | Hspa8 | Alliance of Genome Resources | ||||
| Parkinson's disease | HSPA9* | Hspa9 | Alliance of Genome Resources | ||||
| Parkinson's disease | HTRA2* | Htra2 | Alliance of Genome Resources | ||||
| Parkinson's disease | VDR* | Vdr | Alliance of Genome Resources | ||||
| Parkinson's disease | UCHL1* | Uchl1 | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | TH* | Th | Alliance of Genome Resources | ||||
| Parkinson's disease | TCN2* | Tcn2 | Alliance of Genome Resources | ||||
| Parkinson's disease | TARDBP* | Tardbp | Alliance of Genome Resources | ||||
| Parkinson's disease | SYNJ1* | Synj1 | Alliance of Genome Resources | ||||
| Parkinson's disease | SOD1* | Sod1 | Alliance of Genome Resources | ||||
| Parkinson's disease | SNCB* | Sncb | Alliance of Genome Resources | ||||
| Parkinson's disease | SNCA* | Snca | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | SLC18A2* | Slc18a2 | Alliance of Genome Resources | ||||
| Parkinson's disease | SLC11A2* | Slc11a2 | Alliance of Genome Resources | ||||
| Parkinson's disease | SEPTIN14* | Septin14 | Alliance of Genome Resources | ||||
| Parkinson's disease | S100B* | S100b | Alliance of Genome Resources | ||||
| Parkinson's disease | PTGIS* | Ptgis | Alliance of Genome Resources | ||||
| Parkinson's disease | PRKN* | Prkn | Alliance of Genome Resources | ||||
| Parkinson's disease | POLG* | Polg | Alliance of Genome Resources | ||||
| Parkinson's disease | PLA2G6* | Pla2g6 | Alliance of Genome Resources | ||||
| Parkinson's disease | PINK1* | Pink1 | 2 models | Alliance of Genome Resources | |||
| Parkinson's disease | PHACTR2* | Phactr2 | Alliance of Genome Resources | ||||
| Parkinson's disease | PARP1* | Parp1 | Alliance of Genome Resources | ||||
| Parkinson's disease | PARK7* | Park7 | Alliance of Genome Resources | ||||
| Parkinson's disease | NQO2* | Nqo2 | Alliance of Genome Resources | ||||
| Parkinson's disease | NOS1* | Nos1 | Alliance of Genome Resources | ||||
| Parkinson's disease | NDUFV2* | Ndufv2 | Alliance of Genome Resources | ||||
| Parkinson's disease | NAT2*, NAT1 | Nat1, Nat2, Nat3 | Alliance of Genome Resources | ||||
| Parkinson's disease | MTRR* | Mtrr | Alliance of Genome Resources | ||||
| Parkinson's disease | ND4* | mt-Nd4 | Alliance of Genome Resources | ||||
| Parkinson's disease | ND3* | mt-Nd3 | Alliance of Genome Resources | ||||
| Parkinson's disease | ND2* | mt-Nd2 | Alliance of Genome Resources | ||||
| Parkinson's disease | ND1* | mt-Nd1 | Alliance of Genome Resources | ||||
| Parkinson's disease | MAPT-AS1* | ||||||
| Parkinson's disease | MAPT* | Mapt | Alliance of Genome Resources | ||||
| Parkinson's disease | MAPK3* | Mapk3 | Alliance of Genome Resources | ||||
| Parkinson's disease | MAPK1* | Mapk1 | Alliance of Genome Resources | ||||
| Parkinson's disease | MAOB* | Maob | Alliance of Genome Resources | ||||
| Parkinson's disease | LRRK2* | Lrrk2 | Alliance of Genome Resources | ||||
| Parkinson's disease | KLK6* | Klk6 | Alliance of Genome Resources | ||||
| Parkinson's disease | HTT* | Htt | Alliance of Genome Resources | ||||
| Parkinson's disease | A2M* | A2m | Alliance of Genome Resources | ||||
| Parkinson's disease | AKT1* | Akt1 | Alliance of Genome Resources | ||||
| Parkinson's disease | ANG* | Ang, Ang2, Ang3, Ang4, Ang5, Ang6 | Alliance of Genome Resources | ||||
| Parkinson's disease | ATM* | Atm | Alliance of Genome Resources | ||||
| Parkinson's disease | ATP6* | Atp6-ps, mt-Atp6 | Alliance of Genome Resources | ||||
| Parkinson's disease | ATP13A2* | Atp13a2 | Alliance of Genome Resources | ||||
| Parkinson's disease | CASP3* | Casp3 | Alliance of Genome Resources | ||||
| Parkinson's disease | CASP9* | Casp9 | Alliance of Genome Resources | ||||
| Parkinson's disease | CAST* | Cast | Alliance of Genome Resources | ||||
| Parkinson's disease | CHRNB3* | Chrnb3 | Alliance of Genome Resources | ||||
| Parkinson's disease | CREB1* | Creb1 | Alliance of Genome Resources | ||||
| Parkinson's disease | CYP1A1* | Cyp1a1 | Alliance of Genome Resources | ||||
| Parkinson's disease | DBH* | Dbh | Alliance of Genome Resources | ||||
| Parkinson's disease | DDC* | Ddc | Alliance of Genome Resources | ||||
| Parkinson's disease | DNAJC6* | Dnajc6 | Alliance of Genome Resources | ||||
| Parkinson's disease | DNAJC13* | Dnajc13 | Alliance of Genome Resources | ||||
| Parkinson's disease 15 | FBXO7* | Fbxo7 | Alliance of Genome Resources | ||||
| Parkinson's disease 19A | DNAJC6* | Dnajc6 | Alliance of Genome Resources | ||||
| Parkinson's disease 20 | SYNJ1* | Synj1 | Alliance of Genome Resources | ||||
| Parkinson's disease 22 | CHCHD2*, CHCHD2P9 | Chchd2, Chchd2-ps | Alliance of Genome Resources | ||||
| Parkinson's disease 23 | VPS13C* | Vps13c | Alliance of Genome Resources | ||||
| Parkinson's disease 25 | PTPA* | Ptpa | Alliance of Genome Resources | ||||
| paroxysmal nonkinesigenic dyskinesia 3 | KCNMA1* | Kcnma1 | Alliance of Genome Resources | ||||
| PEHO syndrome | ZNHIT3* | Znhit3 | Alliance of Genome Resources | ||||
| Pick's disease | MAP2K6* | Map2k6 | Alliance of Genome Resources | ||||
| Pick's disease | PSEN1* | Psen1 | Alliance of Genome Resources | ||||
| Pick's disease | MAPT* | Mapt | Alliance of Genome Resources | ||||
| pleomorphic xanthoastrocytoma | BRAF* | Braf | Alliance of Genome Resources | ||||
| polymicrogyria | WDR62* | Wdr62 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia | PRDM13* | Prdm13 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 11 | TBC1D23* | Tbc1d23 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 12 | COASY* | Coasy | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 13 | VPS51* | Vps51 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 15 | CDC40* | Cdc40 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 16 | MINPP1* | Minpp1 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 1A | VRK1* | Vrk1 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 1B | EXOSC3* | Exosc3 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 1C | EXOSC8* | Exosc8 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 1D | EXOSC9* | Exosc9 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 1E | SLC25A46* | Slc25a46 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 1F | EXOSC1* | Exosc1 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 2A | TSEN54* | Tsen54 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 2B | TSEN2* | Tsen2 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 2C | TSEN34* | Tsen34 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 2D | SEPSECS* | Sepsecs | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 2E | VPS53* | Vps53 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 2F | TSEN15* | Tsen15 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 3 | PCLO* | Pclo | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 4 | TSEN54* | Tsen54 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 5 | TSEN54* | Tsen54 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 6 | RARS2* | Rars2 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 7 | TOE1* | Toe1 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 8 | CHMP1A* | Chmp1a | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 9 | AMPD2* | Ampd2 | Alliance of Genome Resources | ||||
| porencephaly | COL4A2* | Col4a2 | Alliance of Genome Resources | ||||
| primary cerebellar degeneration | SIL1* | Sil1 | Alliance of Genome Resources | ||||
| primary progressive multiple sclerosis | IL4R* | Il4ra | Alliance of Genome Resources | ||||
| primary progressive multiple sclerosis | ADAMTS14* | Adamts14 | Alliance of Genome Resources | ||||
| primary progressive multiple sclerosis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| primary progressive multiple sclerosis | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| primary progressive multiple sclerosis | GRN* | Grn | Alliance of Genome Resources | ||||
| prion disease | SOD1* | Sod1 | Alliance of Genome Resources | ||||
| progressive leukoencephalopathy with ovarian failure | AARS2* | Aars2 | Alliance of Genome Resources | ||||
| progressive myoclonus epilepsy | SEMA6B* | Sema6b | Alliance of Genome Resources | ||||
| progressive myoclonus epilepsy | SLC7A6OS* | Slc7a6os | Alliance of Genome Resources | ||||
| progressive myoclonus epilepsy | EPM2A* | Epm2a | Alliance of Genome Resources | ||||
| progressive myoclonus epilepsy 10 | PRDM8* | Prdm8 | Alliance of Genome Resources | ||||
| progressive myoclonus epilepsy 1A | CSTB* | Cstb | Alliance of Genome Resources | ||||
| progressive myoclonus epilepsy 3 | KCTD7* | Kctd7 | Alliance of Genome Resources | ||||
| progressive myoclonus epilepsy 4 | SCARB2* | Scarb2 | Alliance of Genome Resources | ||||
| progressive myoclonus epilepsy 6 | GOSR2* | Gosr2 | Alliance of Genome Resources | ||||
| progressive myoclonus epilepsy 7 | KCNC1* | Kcnc1 | Alliance of Genome Resources | ||||
| progressive myoclonus epilepsy 8 | CERS1* | Cers1 | Alliance of Genome Resources | ||||
| progressive myoclonus epilepsy 9 | LMNB2* | Lmnb2 | Alliance of Genome Resources | ||||
| progressive supranuclear palsy | MAPT* | Mapt | Alliance of Genome Resources | ||||
| progressive supranuclear palsy | MAP2K6* | Map2k6 | Alliance of Genome Resources | ||||
| progressive supranuclear palsy | NAT2*, NAT1 | Nat1, Nat2, Nat3 | Alliance of Genome Resources | ||||
| quadriplegia | IL6* | Il6 | Alliance of Genome Resources | ||||
| relapsing-remitting multiple sclerosis | CSPG4* | Cspg4 | Alliance of Genome Resources | ||||
| relapsing-remitting multiple sclerosis | ADAMTS14* | Adamts14 | Alliance of Genome Resources | ||||
| relapsing-remitting multiple sclerosis | FAS* | Fas | Alliance of Genome Resources | ||||
| relapsing-remitting multiple sclerosis | KLC1* | Klc1 | Alliance of Genome Resources | ||||
| relapsing-remitting multiple sclerosis | NOD2* | Nod2 | Alliance of Genome Resources | ||||
| restless legs syndrome | TF* | Trf | Alliance of Genome Resources | ||||
| RNASET2-deficient cystic leukoencephalopathy | RNASET2* | Rnaset2a, Rnaset2b | Alliance of Genome Resources | ||||
| Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome | TBC1D24* | Tbc1d24 | Alliance of Genome Resources | ||||
| scapuloperoneal spinal muscular atrophy | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
| sepiapterin reductase deficiency | SPR* | Spr | Alliance of Genome Resources | ||||
| severe congenital encephalopathy due to MECP2 mutation | MECP2* | Mecp2 | Alliance of Genome Resources | ||||
| spastic ataxia | COQ4* | Coq4 | Alliance of Genome Resources | ||||
| spastic ataxia | CHP1* | Chp1 | Alliance of Genome Resources | ||||
| spastic ataxia | AFG3L2* | Afg3l2 | Alliance of Genome Resources | ||||
| spastic ataxia 1 | VAMP1* | Vamp1 | Alliance of Genome Resources | ||||
| spastic ataxia 2 | KIF1C* | Kif1c | Alliance of Genome Resources | ||||
| spastic ataxia 3 | MARS2* | Mars2 | Alliance of Genome Resources | ||||
| spastic ataxia 4 | MTPAP* | Mtpap | Alliance of Genome Resources | ||||
| spastic ataxia 5 | AFG3L2* | Afg3l2 | Alliance of Genome Resources | ||||
| spastic ataxia 8 | NKX6-2* | Nkx6-2 | Alliance of Genome Resources | ||||
| spastic quadriplegic cerebral palsy 2 | KANK1* | Kank1 | Alliance of Genome Resources | ||||
| spastic quadriplegic cerebral palsy 3 | ADD3* | Add3 | Alliance of Genome Resources | ||||
| spinal muscular atrophy | AR* | Ar | Alliance of Genome Resources | ||||
| spinal muscular atrophy | VAPB* | Vapb | Alliance of Genome Resources | ||||
| spinal muscular atrophy | HEXB* | Hexb | Alliance of Genome Resources | ||||
| spinal muscular atrophy | DPP6* | Dpp6 | Alliance of Genome Resources | ||||
| spinal muscular atrophy | SMN1*, SMN2 | Smn1 | Alliance of Genome Resources | ||||
| spinal muscular atrophy | ANKRD1* | Ankrd1 | Alliance of Genome Resources | ||||
| spinal muscular atrophy, Jokela type | CHCHD10* | Chchd10 | Alliance of Genome Resources | ||||
| spinal muscular atrophy with lower extremity predominant 1 | DYNC1H1* | Dync1h1 | Alliance of Genome Resources | ||||
| spinal muscular atrophy with lower extremity predominant 2A | BICD2* | Bicd2 | Alliance of Genome Resources | ||||
| spinal muscular atrophy with lower extremity predominant 2B | ND6* | mt-Nd6 | Alliance of Genome Resources | ||||
| spinal muscular atrophy with lower extremity predominant 2B | BICD2* | Bicd2 | Alliance of Genome Resources | ||||
| spinal muscular atrophy with progressive myoclonic epilepsy | ASAH1* | Asah1 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia 44 | GRM1* | Grm1 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia 45 | FAT2* | Fat2 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia 46 | PLD3* | Pld3 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 10 | ATXN10* | Atxn10 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 11 | TTBK2* | Ttbk2 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 12 | PPP2R2B* | Ppp2r2b | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 13 | KCNC3* | Kcnc3 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 15 | ITPR1* | Itpr1 | 2 models | Alliance of Genome Resources | |||
| spinocerebellar ataxia type 19/22 | KCND3* | Kcnd3 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 21 | TMEM240* | Tmem240 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 23 | PDYN* | Pdyn | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 25 | PNPT1* | Pnpt1 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 26 | EEF2* | Eef2 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 29 | ITPR1* | Itpr1 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 31 | BEAN1* | Bean1 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 34 | ELOVL4* | Elovl4 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 35 | TGM6* | Tgm6 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 36 | NOP56* | Nop56 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 37 | DAB1* | Dab1 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 38 | ELOVL5* | Elovl5 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 4 | ZFHX3* | Zfhx3 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 40 | CCDC88C* | Ccdc88c | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 8 | ATXN8* | ||||||
| spinocerebellar ataxia type 8 | ATXN8OS* | ||||||
| spinocerebellar ataxia with axonal neuropathy 2 | SETX* | Setx | Alliance of Genome Resources | ||||
| spinocerebellar ataxia with axonal neuropathy type 3 | COA7* | Coa7 | Alliance of Genome Resources | ||||
| SPOAN syndrome | KLC2* | Klc2 | Alliance of Genome Resources | ||||
| status epilepticus | BDNF* | Bdnf | Alliance of Genome Resources | ||||
| Stiff-Person syndrome | HSD17B4* | Hsd17b4 | Alliance of Genome Resources | ||||
| stress-induced childhood-onset neurodegeneration with variable ataxia and seizures | ADPRS* | Adprs | Alliance of Genome Resources | ||||
| striatonigral degeneration | VAC14* | Vac14 | Alliance of Genome Resources | ||||
| striatonigral degeneration | NUP62* | Nup62 | Alliance of Genome Resources | ||||
| tauopathy | MAPT* | Mapt | Alliance of Genome Resources | ||||
| temporal arteritis | TLR4* | Tlr4 | Alliance of Genome Resources | ||||
| temporal arteritis | CCL2*, CCL13 | Ccl2, Ccl12 | Alliance of Genome Resources | ||||
| temporal arteritis | ELN* | Eln | Alliance of Genome Resources | ||||
| temporal arteritis | FCGR2A*, FCGR2B, FCGR2C | Fcgr2b, Fcgr3 | Alliance of Genome Resources | ||||
| temporal arteritis | FCGR3A*, FCGR3B | Fcgr4 | Alliance of Genome Resources | ||||
| temporal arteritis | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| temporal arteritis | IFNG* | Ifng | Alliance of Genome Resources | ||||
| temporal arteritis | IL4* | Il4 | Alliance of Genome Resources | ||||
| temporal arteritis | IL17A* | Il17a | Alliance of Genome Resources | ||||
| temporal arteritis | IL18* | Il18 | Alliance of Genome Resources | ||||
| temporal arteritis | IL21R* | Il21r | Alliance of Genome Resources | ||||
| temporal arteritis | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
| temporal arteritis | MFGE8* | Mfge8 | Alliance of Genome Resources | ||||
| temporal arteritis | MMP2* | Mmp2 | Alliance of Genome Resources | ||||
| temporal arteritis | MMP9* | Mmp9 | Alliance of Genome Resources | ||||
| temporal arteritis | PTPN22* | Ptpn22 | Alliance of Genome Resources | ||||
| temporal lobe epilepsy | KCNAB1* | Kcnab1 | Alliance of Genome Resources | ||||
| temporal lobe epilepsy | MAPT* | Mapt | Alliance of Genome Resources | ||||
| temporal lobe epilepsy | NPY* | Npy | Alliance of Genome Resources | ||||
| temporal lobe epilepsy | PDYN* | Pdyn | Alliance of Genome Resources | ||||
| temporal lobe epilepsy | AQP4* | Aqp4 | Alliance of Genome Resources | ||||
| torsion dystonia 2 | HPCA* | Hpca | Alliance of Genome Resources | ||||
| torsion dystonia 4 | TUBB4A* | Tubb4a | Alliance of Genome Resources | ||||
| transient cerebral ischemia | BCL2L2*, BCL2L2-PABPN1 | Bcl2l2 | Alliance of Genome Resources | ||||
| transient cerebral ischemia | TFPI* | Tfpi | Alliance of Genome Resources | ||||
| transient cerebral ischemia | SOD1* | Sod1 | Alliance of Genome Resources | ||||
| transient cerebral ischemia | SERPINF1* | Serpinf1 | Alliance of Genome Resources | ||||
| transient cerebral ischemia | NRG1* | Nrg1 | Alliance of Genome Resources | ||||
| transient cerebral ischemia | NAMPT* | Nampt | Alliance of Genome Resources | ||||
| transient cerebral ischemia | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
| transient cerebral ischemia | GOT1* | Got1 | Alliance of Genome Resources | ||||
| transient cerebral ischemia | F12* | F12 | Alliance of Genome Resources | ||||
| transient cerebral ischemia | ERCC1* | Ercc1 | Alliance of Genome Resources | ||||
| transient cerebral ischemia | EPO* | Epo | Alliance of Genome Resources | ||||
| transient cerebral ischemia | CSF3* | Csf3 | Alliance of Genome Resources | ||||
| transverse myelitis | AQP4* | Aqp4 | Alliance of Genome Resources | ||||
| traumatic brain injury | APP* | App | Alliance of Genome Resources | ||||
| tropical spastic paraparesis | NFKB1* | Nfkb1 | Alliance of Genome Resources | ||||
| tropical spastic paraparesis | KLRK1*, KLRC4-KLRK1 | Klrk1 | Alliance of Genome Resources | ||||
| tropical spastic paraparesis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| tropical spastic paraparesis | HNRNPA1*, HNRNPA1L2 | Hnrnpa1, Hnrnpa1l2-ps2 | Alliance of Genome Resources | ||||
| viral encephalitis | CXCL8* | ||||||
| visual epilepsy | TUBA1A* | Tuba1a | Alliance of Genome Resources | ||||
| visual epilepsy | TNF* | Tnf | Alliance of Genome Resources | ||||
| visual epilepsy | TBC1D24* | Tbc1d24 | Alliance of Genome Resources | ||||
| visual epilepsy | FCGR3A*, FCGR3B | Fcgr4 | Alliance of Genome Resources | ||||
| visual epilepsy | NPY* | Npy | Alliance of Genome Resources | ||||
| visual epilepsy | FCGR2A*, FCGR2B, FCGR2C | Fcgr2b, Fcgr3 | Alliance of Genome Resources | ||||
| visual epilepsy | CDKL5* | Cdkl5 | Alliance of Genome Resources | ||||
| visual epilepsy | ASPM* | Aspm | Alliance of Genome Resources | ||||
| visual epilepsy | L2HGDH* | L2hgdh | Alliance of Genome Resources | ||||
| visual epilepsy | APP* | App | Alliance of Genome Resources | ||||
| visual epilepsy | CNTNAP2* | Cntnap2 | Alliance of Genome Resources | ||||
| West syndrome | STXBP1* | Stxbp1 | Alliance of Genome Resources | ||||
| West syndrome | MC2R* | Mc2r | Alliance of Genome Resources | ||||
| X-linked dystonia-parkinsonism | TAF1*, TAF1L | Taf1 | Alliance of Genome Resources | ||||
| X-linked epilepsy with variable learning disabilities and behavior disorders | SYN1* | Syn1 | Alliance of Genome Resources | ||||
| X-linked parkinsonism-spasticity syndrome | ATP6AP2* | Atp6ap2 | Alliance of Genome Resources | ||||
| X-linked spinal muscular atrophy 2 | UBA1* | Uba1 | Alliance of Genome Resources | ||||
| X-linked spinocerebellar ataxia 1 | ATP2B3* | Atp2b3 | Alliance of Genome Resources | ||||
Excel File
|
Transgenes and other genome features developed in mice to model this disease.
|
|||
| Disease Term | Transgenes and Other Genome Features | Mouse Models | |
| adult-onset autosomal dominant demyelinating leukodystrophy | Tg(Plp1-Lmnb1)#Yfu | 1 model | |
| adult-onset autosomal dominant demyelinating leukodystrophy | Tg(Lmnb1)1Yfu | 1 model | |
| adult-onset autosomal dominant demyelinating leukodystrophy | Tg(Plp1-LMNB1)1108Qsp | 1 model | |
| Alexander disease | Tg(GFAP)10Mes | 3 models | |
| Alexander disease | Tg(Gfap-GFAP*R239H)60TMIke | 1 model | |
| Alexander disease | Tg(GFAP)7Mes | 1 model | |
| Alzheimer's disease | Tg(Thy1-APPSweAut)A7Tiwa | 1 model | |
| Alzheimer's disease | Tg(Thy1-APPSweArc)BLngn | 1 model | |
| Alzheimer's disease | Tg(Thy1-APPSwDutIowa)BWevn | 3 models | |
| Alzheimer's disease | Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr | 3 models | |
| Alzheimer's disease | Tg(Thy1-APPSw)10Jiri | 3 models | |
| Alzheimer's disease | Tg(Thy1-APPLon)2Vln | 4 models | |
| Alzheimer's disease | Tg(Thy1-APPArc)M8Cagr | 2 models | |
| Alzheimer's disease | Tg(Thy1-APPSL)28Lpr | 4 models | |
| Alzheimer's disease | Tg(Thy1-APP*Swe*Ind)fAccu | 1 model | |
| Alzheimer's disease | Tg(Thy1-APP*)2Tbay | 1 model | |
| Alzheimer's disease | Tg(Thy1-APP)3Somm | 3 models | |
| Alzheimer's disease | Tg(tetO/Prnp-APP*Swe*Lon)9191Krz | 1 model | |
| Alzheimer's disease | Tg(tetO-MAPT*K280,-luc)#Eman | 1 model | |
| Alzheimer's disease | Tg(tetO-HMOX1)6Hyms | 1 model | |
| Alzheimer's disease | Tg(tetO-CDK5R1/GFP)337Lht | 1 model | |
| Alzheimer's disease | Tg(tetO-APPSwInd)Dbo | 2 models | |
| Alzheimer's disease | Tg(tetO-APPSwInd)107Dbo | 1 model | |
| Alzheimer's disease | Tg(tetO-APPSwInd)102Dbo | 1 model | |
| Alzheimer's disease | Tg(tetO-APPSwInd)18Dbo | 1 model | |
| Alzheimer's disease | Tg(PSEN1H163R)G9Btla | 1 model | |
| Alzheimer's disease | Tg(PSEN1dE9)S9Dbo | 4 models | |
| Alzheimer's disease | Tg(Thy1-MAPT)1Vln | 2 models | |
| Alzheimer's disease | Tg(Thy1-MAPT)2Vln | 2 models | |
| Alzheimer's disease | Tg(Thy1-MAPT)22Schd | 2 models | |
| Alzheimer's disease | Tg(Thy1-MAPT*P301L)2Vln | 1 model | |
| Alzheimer's disease | Tg(Thy1-PSEN1*M146V,-APP*Swe)10Arte | 1 model | |
| Alzheimer's disease | Tg(Thy1-APPSweLon)41Ema | 1 model | |
| Alzheimer's disease | Tg(ACTB-APP*V717F)1Colm | 1 model | |
| Alzheimer's disease | Tg(APP695)3Dbo | 8 models | |
| Alzheimer's disease | Tg(APP)8.9Btla | 1 model | |
| Alzheimer's disease | Tg(APPSw)40Btla | 2 models | |
| Alzheimer's disease | Tg(APPSWE)2576Kha | 13 models | |
| Alzheimer's disease | Tg(APPswe,PSEN1dE9)85Dbo | 6 models | |
| Alzheimer's disease | Tg(APPSwFlLon,PSEN1*M146L*L286V)6799Vas | 8 models | |
| Alzheimer's disease | Tg(APPSwLon)96Btla | 1 model | |
| Alzheimer's disease | Tg(APPV717F)109Ili | 9 models | |
| Alzheimer's disease | Tg(Camk2a-App*,-Apbb1)25Spim | 1 model | |
| Alzheimer's disease | Tg(CMV-IgkvaD11)BCat | 2 models | |
| Alzheimer's disease | Tg(DMD-APP*)7Neve | 1 model | |
| Alzheimer's disease | Tg(DMD-APP*)18Neve | 1 model | |
| Alzheimer's disease | Tg(Eno2-APP*Ind)#Kakiz | 1 model | |
| Alzheimer's disease | Tg(Eno2-PSEN2)2348Ykk | 1 model | |
| Alzheimer's disease | Tg(Eno2-PSEN2*)1480Ykk | 1 model | |
| Alzheimer's disease | Tg(Mapt-MAPT*)#Hanr | 1 model | |
| Alzheimer's disease | Tg(NEFL-APP)#Nalb | 1 model | |
| Alzheimer's disease | Tg(PDGFB-APPInd)F17Plhn | 1 model | |
| Alzheimer's disease | Tg(PDGFB-APPSwDutLon)46Lpr | 2 models | |
| Alzheimer's disease | Tg(PDGFB-APPSwInd)J9Lms | 1 model | |
| Alzheimer's disease | Tg(PDGFB-MAPT*V337M)1Atak | 1 model | |
| Alzheimer's disease | Tg(Prnp-APP*)1Hmor | 1 model | |
| Alzheimer's disease | Tg(Prnp-App/APPswe)E1-2Dbo | 1 model | |
| Alzheimer's disease | Tg(Prnp-APPSweArc)#Rmni | 1 model | |
| Alzheimer's disease | Tg(PRNP-APPSweInd)8Dwst | 3 models | |
| Alzheimer's disease | Tg(PRNP-APPSweInd)19959Dwst | 1 model | |
| Alzheimer's disease | Tg(Prnp-ITM2B/APP695*40)1Emcg | 1 model | |
| Alzheimer's disease | Tg(Prnp-ITM2B/APP695*42)A12Emcg | 1 model | |
| Alzheimer's disease | Tg(Prnp-MAPT)7Vle | 1 model | |
| Alzheimer's disease | Tg(Prnp-MAPT)43Vle | 1 model | |
| Alzheimer's disease | Tg(Prnp-MAPT*K274Q*K281Q)286Lgn | 1 model | |
| Alzheimer's disease | Tg(Prnp-MAPT*P301L)JNPL3Hlmc | 2 models | |
| Alzheimer's disease | Tg(Prnp-MAPT*P301S)PS19Vle | 3 models | |
| Alzheimer's disease 3 | Tg(APPswe,PSEN1dE9)85Dbo | 2 models | |
| Alzheimer's disease 3 | Tg(APPSwFlLon,PSEN1*M146L*L286V)6799Vas | 1 model | |
| Alzheimer's disease 3 | Tg(PSEN1dE9)S9Dbo | 4 models | |
| Alzheimer's disease 3 | Tg(PSEN1H163R)G9Btla | 1 model | |
| Alzheimer's disease 4 | Tg(APP695)3Dbo | 3 models | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G37R)106Dpr | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G37R)42Dpr | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(Myl1-SOD1*G93A)#Amu | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(NEFH)200Jpj | 2 models | |
| amyotrophic lateral sclerosis type 1 | Tg(NFH)120Jpj | 2 models | |
| amyotrophic lateral sclerosis type 1 | Tg(Prnp-Immt/SOD1*G93A)7Gmnf | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(Prnp-SOD1*G37R,-PSEN1)110Dbo | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*)125Dbo | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(Thy1-SOD1*G93A)T3Hgrd | 2 models | |
| amyotrophic lateral sclerosis type 1 | Tg(Thy1-Sncg)HvP36Putt | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(Thy1-DCTN1*G59S)M2Pcw | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*L126Z)#Deng | 2 models | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*L126Z)45Dbo | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*H46R*H48Q)139Dbo | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*H46R*H48Q)58Dbo | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*H46R)LAra | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*H46R)IAra | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*H46R)#Maw | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G127X)716Mrkl | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G93A)dl1Gur | 2 models | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G93A)2Gur | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G93A)1Gur | 6 models | |
| amyotrophic lateral sclerosis type 1 | Tg(Sod1*G86R)M1Jwg | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*)D-14Dbo | 2 models | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*)DF7Yaw | 2 models | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G37R)1Dwc | 2 models | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G37R)9Dpr | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G37R)29Dpr | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G85R/EYFP)737Alho | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G85R/EYFP)641Alho | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G85R)#Roos | 2 models | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G85R)148Dwc | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G85R)74Dwc | 1 model | |
| amyotrophic lateral sclerosis type 10 | Tg(Thy1-TARDBP*)BOddo | 1 model | |
| amyotrophic lateral sclerosis type 10 | Tg(Prnp-TARDBP*A315T)23Jlel | 1 model | |
| amyotrophic lateral sclerosis type 10 | Tg(Prnp-TARDBP)3cPtrc | 1 model | |
| amyotrophic lateral sclerosis type 10 | Tg(CAG-dsRed2/RNAi:Tardbp)6Zxu | 1 model | |
| amyotrophic lateral sclerosis type 10 | Tg(Prnp-TARDBP*A315T)95Balo | 1 model | |
| amyotrophic lateral sclerosis type 10 | Tg(Prnp-TARDBP*Q331K)103Dwc | 1 model | |
| amyotrophic lateral sclerosis type 10 | Tg(Prnp-TARDBP)4Jlel | 1 model | |
| amyotrophic lateral sclerosis type 10 | Tg(TARDBP*A315T)#Jpj | 1 model | |
| amyotrophic lateral sclerosis type 10 | Tg(Thy1-TARDBP)6Singh | 1 model | |
| amyotrophic lateral sclerosis type 10 | Tg(tetO-TARDBP*A315T)13Lmit | 1 model | |
| amyotrophic lateral sclerosis type 10 | Tg(Thy1-TARDBP)4Singh | 2 models | |
| amyotrophic lateral sclerosis type 10 | Tg(tetO-TARDBP)12Vle | 1 model | |
| amyotrophic lateral sclerosis type 10 | Tg(TARDBP*G348C)#Jpj | 1 model | |
| amyotrophic lateral sclerosis type 10 | Tg(tetO-TARDBP*)4Vle | 2 models | |
| amyotrophic lateral sclerosis type 10 | Tg(TARDBP)#Jpj | 1 model | |
| amyotrophic lateral sclerosis type 15 | Tg(Thy1-UBQLN2*P497S)3Mont | 1 model | |
| amyotrophic lateral sclerosis type 15 | Tg(Thy1-UBQLN2*P506T)6Mont | 1 model | |
| amyotrophic lateral sclerosis type 4 | Tg(Prnp-SETX*R2136H)1920Als | 1 model | |
| amyotrophic lateral sclerosis type 6 | Tg(CAG-lacZ,-FUS*R521G,-EGFP)682Gyu | 1 model | |
| amyotrophic lateral sclerosis type 6 | Tg(Prnp-FUS)WT3Cshw | 1 model | |
| amyotrophic lateral sclerosis type 6 | Tg(Prnp-FUS*R521C)3313Ejh | 1 model | |
| amyotrophic lateral sclerosis type 6 | Tg(Thy1-FUS*)1Dit | 1 model | |
| amyotrophic lateral sclerosis type 6 | Tg(Thy1-FUS*)19Vlb | 1 model | |
| amyotrophic lateral sclerosis type 6 | Tg(CAG-lacZ,-FUS,-EGFP)629Gyu | 1 model | |
| amyotrophic lateral sclerosis type 8 | Tg(Thy1-VAPB*P56S,-EGFP)D3Cai | 1 model | |
| arteriovenous malformations of the brain | Tg(tetO-Notch4*)1Rwng | 1 model | |
| autosomal dominant nocturnal frontal lobe epilepsy 3 | Tg(tetO-Chrnb2*V287L)H3Gica | 1 model | |
| brain ischemia | Tg(Notch3*R169C)88Bbb | 1 model | |
| CADASIL 1 | Tg(Notch3*R169C)88Bbb | 1 model | |
| Creutzfeldt-Jakob disease | Tg(Prnp*)#Rgab | 2 models | |
| Creutzfeldt-Jakob disease | Tg(Prnp*D177N*M128V)A21Rchi | 4 models | |
| dentatorubral-pallidoluysian atrophy | Tg(Eno2-ATN1)14Tx | 1 model | |
| dentatorubral-pallidoluysian atrophy | Tg(Eno2-ATN1)3Tx | 1 model | |
| dentatorubral-pallidoluysian atrophy | Tg(Prnp-ATN1)124Dbo | 1 model | |
| dentatorubral-pallidoluysian atrophy | Tg(Prnp-ATN1)150Dbo | 1 model | |
| dentatorubral-pallidoluysian atrophy | Tg(ATN1*)Q129Stsu | 1 model | |
| epilepsy | Tg(Eno2-Scn2a1*)Q54Mm | 3 models | |
| epilepsy | Tg(RP23-65I14)1Jno | 1 model | |
| epilepsy | Tg(RP23-65I14)2Jno | 1 model | |
| epilepsy | Tg(Camk2a-Bdnf)A9Stl | 1 model | |
| familial encephalopathy with neuroserpin inclusion bodies | Tg(Thy1-SERPINI1*G392E)333Icka | 2 models | |
| familial temporal lobe epilepsy 1 | Tg(Lgi1*)#Mpan | 1 model | |
| fragile X-associated tremor/ataxia syndrome | Tg(Pcp2-FMR1*)1Dln | 1 model | |
| fragile X-associated tremor/ataxia syndrome | Tg(tetO-FMR1*,-EGFP)#Rkhu | 2 models | |
| frontotemporal dementia | Tg(Camk2a-MAPT)601Ymot | 1 model | |
| frontotemporal dementia | Tg(Camk2a-MAPT*P301L)D35Jiri | 1 model | |
| frontotemporal dementia | Tg(Prnp-TARDBP*A315T)95Balo | 1 model | |
| frontotemporal dementia | Tg(tetO-CHMP2B*)3Fbga | 1 model | |
| frontotemporal dementia | Tg(Thy1-MAPT*)1Avil | 1 model | |
| frontotemporal dementia | Tg(Thy1-MAPT*K369I)K3Gotz | 1 model | |
| frontotemporal dementia | Tg(Thy1-MAPT*P301S)2541Godt | 1 model | |
| frontotemporal dementia | Tg(Tuba1-MAPT)14Vle | 1 model | |
| frontotemporal dementia | Tg(Thy1-TARDBP)6Singh | 1 model | |
| frontotemporal dementia | Tg(Thy1-MAPT*V337M)1Godt | 1 model | |
| frontotemporal dementia | Tg(Thy1-TARDBP)4Singh | 2 models | |
| frontotemporal dementia | Tg(Camk2a-MAPT*R406W)748Atak | 1 model | |
| frontotemporal dementia | Tg(MAPT*V337M)1Gds | 1 model | |
| frontotemporal dementia | Tg(PDGFB-MAPT*V337M)1Atak | 1 model | |
| frontotemporal dementia | Tg(Prnp-MAPT)7Vle | 1 model | |
| frontotemporal dementia | Tg(Prnp-MAPT)43Vle | 1 model | |
| frontotemporal dementia | Tg(Prnp-MAPT*P301L)JNPL3Hlmc | 1 model | |
| frontotemporal dementia | Tg(Prnp-MAPT*P301S)50Hiw | 1 model | |
| frontotemporal dementia | Tg(Prnp-MAPT*R406W)21807Dwst | 1 model | |
| frontotemporal dementia and/or amyotrophic lateral sclerosis 1 | Tg(C9orf72)500Lpwr | 1 model | |
| generalized epilepsy with febrile seizures plus | Tg(Scn1a*)RH9Aesc | 1 model | |
| Gerstmann-Straussler-Scheinker syndrome | Tg(Prnp*A116V*M128V)1309Jama | 1 model | |
| Gerstmann-Straussler-Scheinker syndrome | Tg(Prnp*P101L)174Sbp | 1 model | |
| Gerstmann-Straussler-Scheinker syndrome | Tg(Prnp*P101L)2862Sbp | 1 model | |
| Gerstmann-Straussler-Scheinker syndrome | Tg(Prnp*P101L)2866Sbp | 3 models | |
| Gerstmann-Straussler-Scheinker syndrome | Tg(Prnp*P101L)2247Sbp | 1 model | |
| Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | Tg(TARDBP*G348C)#Jpj | 1 model | |
| Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | Tg(TARDBP*A315T)#Jpj | 1 model | |
| Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | Tg(TARDBP)#Jpj | 1 model | |
| Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | Tg(Camk2a-Tardbp)#Ckjs | 1 model | |
| Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | Tg(Thy1-TARDBP*)BOddo | 2 models | |
| Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | Tg(Prnp-TARDBP)3cPtrc | 1 model | |
| Huntington's disease | Tg(YAC128)53Hay | 1 model | |
| Huntington's disease | Tg(YAC128)55Hay | 2 models | |
| Huntington's disease | Tg(YAC128)#Hay | 1 model | |
| Huntington's disease | Tg(YAC72)2511Hay | 2 models | |
| Huntington's disease | Tg(UBC-GFP/HTT*84Q)22Shya | 1 model | |
| Huntington's disease | Tg(tetO-HTT*94Q,-lacZ)1Rhn | 1 model | |
| Huntington's disease | Tg(Prnp-SNAP25/HTT*150Q)8Xjl | 1 model | |
| Huntington's disease | Tg(Prnp-HTT*82Q,KRT14-EGFP)C63Dbo | 1 model | |
| Huntington's disease | Tg(Prnp-HTT*82Q)61Gschi | 1 model | |
| Huntington's disease | Tg(Prnp-HTT*82Q)52Caro | 1 model | |
| Huntington's disease | Tg(Prnp-HTT*82Q)8AGschi | 1 model | |
| Huntington's disease | Tg(Ppp1r1b-HTT*)1Meeh | 1 model | |
| Huntington's disease | Tg(Plp1-HTT*150Q)4aXjl | 1 model | |
| Huntington's disease | Tg(HTT*/EGFP)190Nn | 1 model | |
| Huntington's disease | Tg(HTT*/EGFP)150Nn | 1 model | |
| Huntington's disease | Tg(HTT*)NXwy | 1 model | |
| Huntington's disease | Tg(HTT*)LXwy | 1 model | |
| Huntington's disease | Tg(HTT*)1Xwy | 1 model | |
| Huntington's disease | Tg(HTT*97Q)IXwy | 2 models | |
| Huntington's disease | Tg(HDexon1)62Gpb | 3 models | |
| Huntington's disease | Tg(HDexon1)61Gpb | 1 model | |
| Huntington's disease | Tg(HD)63Aron | 1 model | |
| Huntington's disease | Tg(HD82Gln)81Gschi | 3 models | |
| Huntington's disease | Tg(GFAP-HTT*160Q)31Xjl | 1 model | |
| Huntington's disease | Tg(GFAP-HTT*160Q)1Xjl | 1 model | |
| Huntington's disease | Tg(CMV-HTT*89Q)ATag | 2 models | |
| Huntington's disease | Tg(CMV-HTT*48Q)BTag | 2 models | |
| Huntington's disease | Tg(CAG-Ppard*E411P)#Als | 1 model | |
| Huntington's disease-like 2 | Tg(JPH3*)CXwy | 1 model | |
| Huntington's disease-like 2 | Tg(JPH3-GFP,-JPH3*)GXwy | 1 model | |
| hydrocephalus | Tg(Sox3)1Pqt | 1 model | |
| Kennedy's disease | Tg(ACTA1-Ar)141Kyjo | 1 model | |
| Kennedy's disease | Tg(Prnp-AR*112Q)#Deme | 1 model | |
| Kennedy's disease | Tg(CAG-AR*97Q)7-8Sobue | 1 model | |
| Kennedy's disease | Tg(AR*100Q)C32Als | 1 model | |
| Kennedy's disease | Tg(AR*100Q)C25Als | 1 model | |
| Kennedy's disease | Tg(AR*100Q)#Als | 1 model | |
| Lafora disease | Tg(CAG-EPM2A*C266S)1Bmin | 1 model | |
| leukoencephalopathy with vanishing white matter | Tg(Plp1-Eif2ak3*)18Pop | 1 model | |
| Machado-Joseph disease | Tg(Prnp-ATXN3*148Q)NLS.28Olri | 1 model | |
| Machado-Joseph disease | Tg(Prnp-ATXN3*148Q)148.19Olri | 1 model | |
| Machado-Joseph disease | Tg(Prnp-ATXN3*79Q)#Hlw | 1 model | |
| Machado-Joseph disease | Tg(Prnp-ATXN3*70Q)70.61Olri | 1 model | |
| Machado-Joseph disease | Tg(Pcp2-ATXN3*69Q)bHirai | 1 model | |
| Machado-Joseph disease | Tg(Htt-ATXN3*148Q)3746Thsc | 1 model | |
| Machado-Joseph disease | Tg(CMV-ATXN3*94Q)94Pama | 2 models | |
| Machado-Joseph disease | Tg(ATXN3*)84.2Cce | 3 models | |
| Machado-Joseph disease | Tg(ATXN3*)67.2Cce | 2 models | |
| Machado-Joseph disease | Tg(CMV-ATXN3*135Q)CPama | 1 model | |
| malignant astrocytoma | Tg(GFAP-SRC)2Aag | 1 model | |
| malignant astrocytoma | Tg(GFAP-TAg121)1Tvd | 2 models | |
| malignant astrocytoma | Tg(GFAP-SRC)1Aag | 1 model | |
| malignant astrocytoma | Tg(GFAP-Hras1)2Agu | 1 model | |
| medulloblastoma | Tg(Neurod2-Smo*A2)#Jols | 1 model | |
| medulloblastoma | Tg(Neurod2-Smo*A1)199Jols | 3 models | |
| medulloblastoma | Tg(tetO-TAg,CMV-rtTA)123Yihu | 1 model | |
| medulloblastoma | Tg(tetO-MYCN,-luc)#Waw | 2 models | |
| medulloblastoma | Tg(tetO-Ifng)184Pop | 2 models | |
| motor neuron disease | Tg(Thy1-BSCL2*N88S)1Dit | 1 model | |
| multiple sclerosis | Tg(Gfap-TNF*)K21Gkl | 2 models | |
| multiple sclerosis | Tg(H2-Kb-Tcra,-Tcrb)1640Kurs | 1 model | |
| multiple sclerosis | Tg(Mbp-Pad2)28Fgm | 2 models | |
| multiple sclerosis | Tg(PLP1*)4Rsj | 1 model | |
| multiple sclerosis | Tg(Tnf)6074Gkl | 2 models | |
| multiple system atrophy | Tg(Mbp-SNCA)29Ema | 1 model | |
| multiple system atrophy | Tg(Cnp-SNCA)M2Vle | 1 model | |
| multiple system atrophy | Tg(Plp1-SNCA)1Haa | 1 model | |
| multiple system atrophy | Tg(Mbp-SNCA)1Ema | 1 model | |
| neurodegeneration with brain iron accumulation 3 | Tg(Prnp-FTL*)4Ruvi | 1 model | |
| neurodegeneration with brain iron accumulation 3 | Tg(PGK1-FTL*)#Sle | 1 model | |
| Parkinson's disease | Tg(Th-Twnk*,-EGFP)2Gcor | 1 model | |
| Parkinson's disease | Tg(Th-SNCA*A30P*A53T)39Eric | 1 model | |
| Parkinson's disease | Tg(Th-SNCA*)1.2Ccs | 1 model | |
| Parkinson's disease | Tg(Th-SNCA)5Eric | 2 models | |
| Parkinson's disease | Tg(tetO-SNCA)0Olri | 1 model | |
| Parkinson's disease | Tg(tetO-HMOX1)6Hyms | 1 model | |
| Parkinson's disease | Tg(Snca-SNCA/GFP)#Jyl | 1 model | |
| Parkinson's disease | Tg(PDGF-S100B)36Cqin | 1 model | |
| Parkinson's disease | Tg(Gfap-rtTA,tetO-MAOB,-lacZ)1Jkan | 1 model | |
| Parkinson's disease | Tg(DBH-SNCA)#Dwei | 1 model | |
| Parkinson's disease | Tg(CAG-SNCA*)1.1Ccs | 1 model | |
| Parkinson's disease 1 | Tg(Thy1-SNCA)61Ema | 1 model | |
| Parkinson's disease 1 | Tg(Th-SNCA*)1702Yosh | 1 model | |
| Parkinson's disease 1 | Tg(Snca-SNCA)#Galt | 1 model | |
| Parkinson's disease 1 | Tg(SNCA*E46K)3Elan | 1 model | |
| Parkinson's disease 1 | Tg(SNCA)ARyot | 1 model | |
| Parkinson's disease 1 | Tg(Prnp-SNCA*A53T)AAub | 2 models | |
| Parkinson's disease 1 | Tg(Prnp-SNCA*A53T)83Vle | 2 models | |
| Parkinson's disease 1 | Tg(Prnp-SNCA*A53T)25Mkle | 1 model | |
| Parkinson's disease 1 | Tg(PDGFB-SNCA/EGFP)78Ema | 1 model | |
| Parkinson's disease 1 | Tg(PDGFB-SNCA*A53T)8Ema | 1 model | |
| Parkinson's disease 1 | Tg(PDGFB-SNCA)4Ema | 1 model | |
| Parkinson's disease 1 | Tg(Thy1-SNCA*E57K)16Ema | 1 model | |
| Parkinson's disease 1 | Tg(THY1-SNCA*A53T)M53Sud | 1 model | |
| Parkinson's disease 1 | Tg(Thy1-SNCA*)#Ztzh | 1 model | |
| Parkinson's disease 1 | Tg(Thy1-SNCA*A30P)18Pjk | 1 model | |
| Parkinson's disease 2 | Tg(Slc6a3-PARK2*Q311X)AXwy | 1 model | |
| Parkinson's disease 4 | Tg(Thy1-Snca)1S13Putt | 1 model | |
| Parkinson's disease 8 | Tg(PDGFB-LRRK2*G2019S)32Hlw | 1 model | |
| Parkinson's disease 8 | Tg(Lrrk2*G2019S)2Yue | 1 model | |
| Parkinson's disease 8 | Tg(PDGFB-LRRK2*R1441C)31Hlw | 1 model | |
| paroxysmal nonkinesigenic dyskinesia 1 | Tg(Pnkd*A7V*A9V,-DsRed)671Ljp | 1 model | |
| paroxysmal nonkinesigenic dyskinesia 1 | Tg(Pnkd*A7V*A9V,-DsRed)704Ljp | 1 model | |
| Pelizaeus-Merzbacher disease | Tg(Plp)66Kan | 2 models | |
| Pelizaeus-Merzbacher disease | Tg(Plp)72Kan | 1 model | |
| Pelizaeus-Merzbacher disease | Dp(XTceal3-Plp1)1Gmh | 1 model | |
| Pick's disease | Tg(Thy1-MAPT*L266V*G272V)13Ema | 1 model | |
| spinocerebellar ataxia type 1 | Tg(Pcp2-ATXN1*82Q)5Horr | 1 model | |
| spinocerebellar ataxia type 1 | Tg(tetO-ATXN1*82Q)#Horr | 1 model | |
| spinocerebellar ataxia type 10 | Tg(Prnp-lacZ/ATXN10*)#Teas | 1 model | |
| spinocerebellar ataxia type 14 | Tg(tetO-PRKCG*S361G,-GFP)3Jpka | 1 model | |
| spinocerebellar ataxia type 17 | Tg(Prnp-TBP*)105Xjl | 1 model | |
| spinocerebellar ataxia type 17 | Tg(Prnp-TBP*)71-27Xjl | 1 model | |
| spinocerebellar ataxia type 17 | Tg(Prnp-TBP*)71-16Xjl | 1 model | |
| spinocerebellar ataxia type 17 | Tg(Pcp2-TBP*)69Hmhl | 1 model | |
| spinocerebellar ataxia type 2 | Tg(Pcp2-ATXN2*127Q)#Plt | 1 model | |
| spinocerebellar ataxia type 2 | Tg(ATXN2*72Q)#Plt | 1 model | |
| spinocerebellar ataxia type 5 | Tg(tetO-SPTBN2*)#Lpwr | 1 model | |
| spinocerebellar ataxia type 7 | Tg(Prnp-ATXN7*92Q)1963Als | 1 model | |
| spinocerebellar ataxia type 7 | Tg(Pcp2-SCA7)P7EJman | 1 model | |
| spinocerebellar ataxia type 7 | Tg(GFAP-ATXN7*92Q)2542Als | 1 model | |
| spinocerebellar ataxia type 7 | Tg(RHO-SCA7)R7EJman | 1 model | |
| spinocerebellar ataxia type 7 | Tg(GFAP-ATXN7*92Q)2521Als | 1 model | |
| spinocerebellar ataxia type 7 | Tg(Prnp-ATXN7*92Q)6076Als | 1 model | |
| tauopathy | Tg(Prnp-MAPT*)2652Gds | 1 model | |
| tauopathy | Tg(Mapt-MAPT*)#Hanr | 1 model | |
| tauopathy | Tg(Prnp-MAPT*P301S)50Hiw | 1 model | |
| torsion dystonia 1 | Tg(Eno2-TOR1A*)13Shas | 1 model | |
| torsion dystonia 1 | Tg(CMV-TOR1A*)1Nush | 1 model | |
| torsion dystonia 1 | Tg(CMV-TOR1A*)2Nush | 1 model | |